<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">NRO</journal-id>
<journal-id journal-id-type="hwp">spnro</journal-id>
<journal-id journal-id-type="nlm-ta">Neuroscientist</journal-id>
<journal-title>The Neuroscientist</journal-title>
<issn pub-type="ppub">1073-8584</issn>
<issn pub-type="epub">1089-4098</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1073858411419047</article-id>
<article-id pub-id-type="publisher-id">10.1177_1073858411419047</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Injured and Regenerating Nervous System</article-title>
<subtitle>Immunoglobulin Superfamily Members as Key Players</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Irintchev</surname><given-names>Andrey</given-names></name>
<xref ref-type="aff" rid="aff1-1073858411419047">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Schachner</surname><given-names>Melitta</given-names></name>
<xref ref-type="aff" rid="aff2-1073858411419047">2</xref>
<xref ref-type="aff" rid="aff3-1073858411419047">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-1073858411419047"><label>1</label>Neuroscience Laboratory, Department of Otorhinolaryngology, University of Jena, Germany</aff>
<aff id="aff2-1073858411419047"><label>2</label>Zentrum für Molekulare Neurobiologie, Universität Hamburg, Hamburg, Germany</aff>
<aff id="aff3-1073858411419047"><label>3</label>Keck Center for Collaborative Neuroscience, Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, USA</aff>
<author-notes>
<corresp id="corresp1-1073858411419047">Andrey Irintchev, Department of Otorhinolaryngology, Friedrich Schiller University Jena, Lessingstrasse 2, D-07740 Jena, Germany Email: <email>andrey.irintchev@med.uni-jena.de</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>18</volume>
<issue>5</issue>
<fpage>452</fpage>
<lpage>466</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Understanding restricted functional recovery and designing efficient treatments to alleviate dysfunction after injury of the nervous system remain major challenges in neuroscience and medicine. Numerous molecules of potential significance in neural repair have been identified in vitro, but only few of these have proved to be of major importance in vivo up to now. Among the molecules involved in regeneration are several members of the immunoglobulin superfamily, most notably the neural cell adhesion molecules L1, its close homologue CHL1, and NCAM and, in particular, its polysialic acid glycan moiety. Sufficient evidence is now available to justify the statement that these molecules are major players not only in nervous system development but also in the adult during neural repair and synaptic plasticity. Importantly, insights into the functions of these molecules in promoting or inhibiting functional recovery have allowed the design and assessment of therapeutic approaches in animal models of central nervous system injury that could prove to be applicable in clinical settings.</p>
</abstract>
<kwd-group>
<kwd>close homologue of L1</kwd>
<kwd>injury</kwd>
<kwd>L1</kwd>
<kwd>myelin-associated glycoprotein</kwd>
<kwd>nervous system</kwd>
<kwd>neural cell adhesion molecule</kwd>
<kwd>peripheral nerve</kwd>
<kwd>regeneration</kwd>
<kwd>spinal cord</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The immunoglobulin superfamily (IgSF) is one of the most ancient and diverse groups of proteins, a “master superfamily of interaction molecules,” including thousands of different proteins expressed in diverse organs and systems of vertebrates and invertebrates (<xref ref-type="bibr" rid="bibr5-1073858411419047">Barclay 2003</xref>; <xref ref-type="bibr" rid="bibr107-1073858411419047">Shapiro and others 2007</xref>). The evolutionary success of the IgSF members is related to one common structural element, a variable domain that shares amino acid sequence similarities with immunoglobulins and allows versatile molecular interactions. The origin of the IgSF concept dates back to the late 1970s when a protein expressed in the brain, the thymocyte differentiation antigen 1 (Thy-1), was identified as an immunoglobulin-like molecule (<xref ref-type="bibr" rid="bibr21-1073858411419047">Campbell and others 1979</xref>). Since then, the number of neural IgSF members and understanding of their molecular structure, interaction partners, and signaling mechanisms have dramatically increased (<xref ref-type="bibr" rid="bibr19-1073858411419047">Brümmendorf and Rathjen 1996</xref>; <xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner 2007</xref>; <xref ref-type="bibr" rid="bibr101-1073858411419047">Rougon and Hobert 2003</xref>; <xref ref-type="bibr" rid="bibr107-1073858411419047">Shapiro and others 2007</xref>; <xref ref-type="bibr" rid="bibr114-1073858411419047">Walsh and Doherty 1997</xref>). In addition to knowledge on structure-function relationships of IgSF members in vitro, substantial progress has been made in understanding their functions in vivo. It is now well established that several molecules, known as immunoglobulin cell adhesion molecules (IgCAMs), are crucial for normal brain development. Genetic ablation of the IgCAMs NCAM, L1, and CHL1 leads to structural aberrations in the brain and abnormal behavioral traits in mice, and mutations in the human genes encoding these proteins are linked to major neuropsychiatric disorders, such as schizophrenia (<italic>NCAM, L1, CHL1</italic>) and mood disorders (<italic>NCAM</italic>; <xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner 2007</xref>). The origins of such disorders are due to disturbances of developmental processes mediated by IgCAMs that include cell proliferation and migration, neuritogenesis, axonal fasciculation, synaptogenesis, and stabilization of synapses. An impressive development was the identification of several IgCAMs expressed in the adult brain as major determinants of synaptic plasticity and thus of learning and memory (<xref ref-type="bibr" rid="bibr40-1073858411419047">Dityatev and others 2008</xref>). Not least, evidence has accumulated indicating that IgSF molecules are involved in repair of the injured adult nervous system (<xref ref-type="bibr" rid="bibr80-1073858411419047">Loers and Schachner 2007</xref>; <xref ref-type="bibr" rid="bibr123-1073858411419047">Zhang Y and others 2008</xref>). Considering the properties identified in vitro, such as promotion of cell survival and neuritogenesis, the list of IgSF molecules of interest for regeneration after injury in the central and peripheral nervous system is remarkable, but convincing evidence for major impacts on neural repair in vivo is limited to a few IgCAMs—NCAM, L1, and CHL1—which are the main topic of this review.</p>
<sec id="section1-1073858411419047">
<title>Molecular and Functional Diversity of IgCAMs</title>
<p>The functional roles that IgCAMs may play in neural repair are considered to be multiple, and even a single molecule can have both regeneration-promoting and - inhibiting properties depending on the cellular context that such molecules are expressed in. To clarify this notion, it is worthwhile to consider some structural features providing a basis for a high functional diversity of IgCAMs at different levels (<xref ref-type="fig" rid="fig1-1073858411419047">Fig. 1</xref>) (<xref ref-type="bibr" rid="bibr19-1073858411419047">Brümmendorf and Rathjen 1996</xref>; <xref ref-type="bibr" rid="bibr73-1073858411419047">Kleene and Schachner 2004</xref>; <xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner 2007</xref>; <xref ref-type="bibr" rid="bibr105-1073858411419047">Schmid and Maness 2008</xref>). First, several structurally distinct Ig domains allow interactions with the same molecule (homophilic binding) and non-like molecules (heterophilic interactions) located within the same cell surface membrane (<italic>cis-</italic>interactions) and on neighboring cells (<italic>trans</italic>-interactions). Alternatively spliced isoforms with small inserted sequences intra- and extracellularly convey, respectively, distinct signal transduction and recognition features of IgCAMs. In addition, several IgCAMs possess fibronectin type 3 (FN3)–like domains, which bind to molecules distinct from the binding partners of the Ig domains. As a result of the diversity of binding domains, L1, for example, can bind to several molecules, including L1, NCAM, neuropilin-1, integrins, TAG-1 (transient axonal glycoprotein-1), F3/contactin, CD9, and CD24 (<xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner 2007</xref>). Second, posttranslational modifications lead to developmentally and cellular activity regulated glycosylation patterns that alter the functional properties of IgCAMs (<xref ref-type="bibr" rid="bibr73-1073858411419047">Kleene and Schachner 2004</xref>). A most striking and well-known example is the unusual glycan α2,8 polysialic acid (PSA), a linear homopolymer attached to the fifth Ig domain of NCAM that can contain up to 200 sialic acid residues (<xref ref-type="fig" rid="fig1-1073858411419047">Fig. 1</xref>). PSA reduces the adhesive properties of NCAM via its highly negative charge and/or large hydration volume and could also act in a heterophilic mode by affecting interactions of NCAM with other molecules such as heparan sulfate proteoglycans or, surprisingly, histone H1 (<xref ref-type="bibr" rid="bibr92-1073858411419047">Mishra and others 2010</xref>). Third, the extracellular domains of IgCAMs can be enzymatically cleaved by members of the ADAM (a disintegrin and metalloprotease) family, leading to enrichment of the extracellular matrix with functionally active IgCAM fragments (<xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner 2007</xref>). Thus, for example, L1 cleavage promotes neuronal cell migration and neurite outgrowth. Fourth, additional functional and structural diversity is achieved by alternative splicing of the IgCAMs (<xref ref-type="fig" rid="fig1-1073858411419047">Fig. 1</xref>) (<xref ref-type="bibr" rid="bibr41-1073858411419047">Doherty and others 2000</xref>; <xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner 2007</xref>). For NCAM, a single gene gives rise to three major isoforms, NCAM120, NCAM140, and NCAM180 (<xref ref-type="fig" rid="fig1-1073858411419047">Fig. 1</xref>). In addition, a variable alternatively spliced exon (VASE) can be inserted in the fourth Ig domain, causing down-regulation of NCAM-mediated axon growth or truncation and secretion of the NCAM extracellular domain.</p>
<fig id="fig1-1073858411419047" position="float">
<label>Figure 1.</label>
<caption>
<p>Structure of immunoglobulin cell adhesion molecules (IgCAMs). Shown are molecules belonging to three different subfamilies defined by their extracellular domain organization (<xref ref-type="bibr" rid="bibr19-1073858411419047">Brümmendorf and Rathjen 1996</xref>; <xref ref-type="bibr" rid="bibr35-1073858411419047">Cunningham 1995</xref>): the n/0 subfamily (n Ig domains, 0 FN3 repeats, MAG), the 5/2 subfamily (NCAM), and the 6/5 (L1) subfamily (L1, CHL1). <italic>Extra</italic> and <italic>intra</italic> indicate the extra- and intracellular side of the cell surface membrane presented as a horizontal gray line. NCAM120 is attached to the membrane via a GPI (glycosylphosphatidylinositol) anchor. The other IgCAMs are type I proteins with a transmembrane and an intracellular domain. NCAM is encoded by a single gene, and its three major isoforms with apparent molecular weights of 120, 140, and 180 kD (NCAM120, NCAM140, and NCAM180, respectively) are generated by alternative splicing. NCAM120 and NCAM140 are expressed by glial cells and NCAM140 and NCAM180 by neurons. Alternatively spliced sequences are found in the cytoplasmic domain and the second Ig domain of L1 (<xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner 2007</xref>), and the cytoplasmic domain of MAG yields a large (L) or a small (S) MAG isoform (<xref ref-type="bibr" rid="bibr99-1073858411419047">Quarles 2007</xref>). All IgCAMs are glycoproteins, and potential glycosylation sites attached to the protein backbone (<xref ref-type="bibr" rid="bibr60-1073858411419047">Holm and others 1996</xref>; <xref ref-type="bibr" rid="bibr73-1073858411419047">Kleene and Schachner 2004</xref>; <xref ref-type="bibr" rid="bibr75-1073858411419047">Kruse and others 1984</xref>) are indicated by green circles. The human natural killer cell glycan (3′ sulfoglucuronyl β1,3 galactoside), known as HNK-1 epitope, is expressed on all IgCAM members shown here. The glycosylation of NCAM is unusual in that it carries, in addition to other glycans, α2,8 polysialic acid (PSA) polymers within its fifth Ig domain. The extracellular domains of IgCAMs can be enzymatically cleaved by members of the ADAM (a disintegrin and metalloprotease) family (“Shedding”) (<xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner 2007</xref>).</p>
</caption>
<graphic xlink:href="10.1177_1073858411419047-fig1.tif"/>
</fig>
<p>IgCAMs are transmembrane or glycosylphosphatidylinositol (GPI) membrane-anchored glycoproteins with intracellular domains linking them directly or indirectly to the cytoskeleton, in addition to linking them to signaling pathways. By influencing assembly and stabilization of cytoskeletal elements like actin filaments and microtubules, IgCAMs can modulate cell motility and neurite outgrowth (<xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner 2007</xref>). These influences are mediated by interactions with scaffold molecules such as spectrin and growth-associated protein 43 (GAP-43) for NCAM, as well as ankyrin, ERM (ezrin, radixin, and moesin) proteins, and doublecortin for L1 family members (L1 and CHL1) (<xref ref-type="table" rid="table1-1073858411419047">Table 1</xref>). IgCAMs also function as directly signaling and co-signaling molecules by, for instance, binding to and thus modulating the activity of receptors such as neuropilin-1, glial cell line–derived neurotrophic factor family receptor α1 (GFRα1), and fibroblast growth factor receptor (FGFR) (<xref ref-type="table" rid="table1-1073858411419047">Table 1</xref>). Therefore, IgCAMs are not simply cell surface molecules mediating cell adhesion. They are implicated in downstream effects and can modulate, as a result of versatile binding properties, a variety of cellular processes by combinatorial patterns of <italic>trans</italic>- and <italic>cis</italic>-interaction partners (<xref ref-type="table" rid="table1-1073858411419047">Table 1</xref>) (<xref ref-type="bibr" rid="bibr79-1073858411419047">Loers and others 2005</xref>; <xref ref-type="bibr" rid="bibr80-1073858411419047">Loers and Schachner 2007</xref>; <xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner 2007</xref>). Moreover, IgCAMs can impede or enhance these processes depending on the cell type in which they are expressed, their subcellular localization, molecular interaction partners, and spatial presentation of these interaction partners. For example, <italic>cis</italic>-interactions of L1 with integrins result in enhanced axon growth, whereas L1 <italic>cis</italic>-interactions with neuropilin-1 lead to growth cone collapse and inhibition of axon growth (<xref ref-type="table" rid="table1-1073858411419047">Table 1</xref>). NCAM cleavage promotes neurite outgrowth in hippocampal neurons but down-regulates outgrowth and branching in cortical neurons in vitro (<xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner 2007</xref>). In addition, neurite outgrowth on astrocytes is reduced if CHL1 is simultaneously present on neurons and glial cells compared with expression on neurons or astrocytes alone (<xref ref-type="bibr" rid="bibr66-1073858411419047">Jakovcevski, Wu, and others 2007</xref>).</p>
<table-wrap id="table1-1073858411419047" position="float">
<label>Table 1.</label>
<caption>
<p>Major IgCAM Interaction Partners, Co-signaling Receptors, and Downstream Cellular Pathways</p>
</caption>
<graphic alternate-form-of="table1-1073858411419047" xlink:href="10.1177_1073858411419047-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">IgCAM</th>
<th align="center">Interaction Partners</th>
<th align="center">Signaling Pathways</th>
<th align="center">Cellular Effects</th>
</tr>
</thead>
<tbody>
<tr>
<td>NCAM140, NCAM180</td>
<td>GFRα1</td>
<td>Fyn, FAK</td>
<td>Cell survival</td>
</tr>
<tr>
<td/>
<td>FGFR</td>
<td>PLCγ, DAG, AA, Ca<sup>2+</sup>, CaMKII-α</td>
<td>Cell survival, axon growth</td>
</tr>
<tr>
<td/>
<td>Spectrin, RPTPα</td>
<td>Fyn/Ras, MEK1,2, ERK1,2/PKC</td>
<td>Axon growth</td>
</tr>
<tr>
<td>L1</td>
<td>p90<sup>rsk</sup>, CKII, ERK2</td>
<td>PI3K, Akt, BAD</td>
<td>Cell survival</td>
</tr>
<tr>
<td>L1, CHL1</td>
<td>β1-integrins</td>
<td>PI3K, ERK1,2</td>
<td>Axon growth, cell migration</td>
</tr>
<tr>
<td>L1, CHL1</td>
<td>NP-1</td>
<td>FAK, ERK1,2</td>
<td>Axon repulsion, growth cone collapse</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1073858411419047">
<p>Adapted from <xref ref-type="bibr" rid="bibr79-1073858411419047">Loers and others (2005)</xref>, <xref ref-type="bibr" rid="bibr80-1073858411419047">Loers and Schachner (2007)</xref>, <xref ref-type="bibr" rid="bibr82-1073858411419047">Maness and Schachner (2007)</xref>, <xref ref-type="bibr" rid="bibr105-1073858411419047">Schmid and Maness (2008)</xref>, and <xref ref-type="bibr" rid="bibr114-1073858411419047">Walsh and Doherty (1997)</xref>. GFRα1 = GDNF (glial cell line–derived neurotrophic factor) family receptor α1; FAK = focal adhesion kinase; FGFR = fibroblast growth factor receptor; PLCγ = phospholipase Cγ; DAG = diacylglycerol; AA = arachidonic acid; CaMKII-α = Ca<sup>2+</sup>/calmodulin-dependent protein kinase α, RPTPα = receptor protein phosphatase α; MEK = mitogen-activated protein kinase kinase; ERK = extracellular signal-regulated kinase; PKC = protein kinase C; p90<sup>rsk</sup> = p90 ribosomal s6 kinase; CK II = casein kinase II; PI3K = phosphatidylinositol-3′ kinase; BAD = Bcl-2 (B cell lymphoma 2)–associated death promoter.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section2-1073858411419047">
<title>From the Cell In Vitro to the Injured Nervous System: The Challenge to Understand Regeneration</title>
<p>Molecular and cell biological studies have provided a wealth of knowledge indicating that IgCAMs play key roles in determining the outcome of central nervous system (CNS) and peripheral nervous system (PNS) injury. Understanding of these functions in vivo is, however, a challenge considering the complexity of the nervous system and the wide spectrum of injury-evoked responses in different molecular and cellular contexts and functional circuitries. In the injured CNS of adult mammals, the overall failure of regeneration and the limited functional recovery are generally attributed to 1) restricted intrinsic capacity of neurons to regenerate their damaged axons and 2) nonpermissiveness for axon growth of the environment (<xref ref-type="bibr" rid="bibr9-1073858411419047">Becker and Becker 2007a</xref>, <xref ref-type="bibr" rid="bibr10-1073858411419047">2007b</xref>; <xref ref-type="bibr" rid="bibr54-1073858411419047">Giger and others 2010</xref>). In the adult PNS, axotomized neurons are capable of regeneration, and the environment in the damaged peripheral nerve supports axon growth (<xref ref-type="bibr" rid="bibr54-1073858411419047">Giger and others 2010</xref>). Peripheral nerve regeneration is successful in that the target organ can be abundantly reinnervated but, paradoxically, the functional outcome after PNS injury is often poor (<xref ref-type="bibr" rid="bibr81-1073858411419047">Lundborg and Rosén 2007</xref>; <xref ref-type="bibr" rid="bibr106-1073858411419047">Scholz and others 2009</xref>). The IgCAMs on which this review is focused—namely, NCAM, L1, and CHL1—are generally considered, based on their in vitro properties, regeneration-promoting molecules. In line with this notion, in vivo evidence indicates that limited expression of L1 and NCAM in the adult CNS significantly contributes to regenerative failure. At the same time, recent studies unexpectedly revealed that IgSF molecules, such as CHL1 and L1, which were generally considered permissive molecules, limit recovery of function after CNS and PNS injury, respectively. The following sections summarize some major findings elucidating the diverse implementation of IgCAMs (NCAM, L1, CHL1, and MAG) in neural repair in adult mammals.</p>
</sec>
<sec id="section3-1073858411419047">
<title>IgCAMs Regulate the Intrinsic Axon Growth Potential of Injured CNS Neurons</title>
<p>NCAM, L1, and CHL1 are expressed in most CNS neurons, and their expression is developmentally regulated (<xref ref-type="bibr" rid="bibr17-1073858411419047">Bonfanti 2006</xref>; Hillenbrand and others1999; <xref ref-type="bibr" rid="bibr62-1073858411419047">Hortsch 2003</xref>). The overall IgCAM expression is lower in adult than in embryonic brains, and the transition of an embryonic to adult pattern of protein expression is accompanied by changes in IgCAM glycosylation patterns, for example, reduction in NCAM polysialylation (i.e., “embryonic” NCAM expression; <xref ref-type="bibr" rid="bibr73-1073858411419047">Kleene and Schachner 2004</xref>). Developmental changes in IgCAM expression have been proposed to underlie reduced regeneration (sprouting and elongation) of damaged CNS axons in adult compared with embryonic/postnatal birds and mammals (<xref ref-type="bibr" rid="bibr15-1073858411419047">Blackmore and Letourneau 2006a</xref>, <xref ref-type="bibr" rid="bibr16-1073858411419047">2006b</xref>). Despite age-related decrease, the production of NCAM, L1, and CHL1 proteins is maintained at varying levels in most adult neurons (<xref ref-type="bibr" rid="bibr17-1073858411419047">Bonfanti 2006</xref>; <xref ref-type="bibr" rid="bibr59-1073858411419047">Hillenbrand and others 1999</xref>; <xref ref-type="bibr" rid="bibr60-1073858411419047">Holm and others 1996</xref>; <xref ref-type="bibr" rid="bibr61-1073858411419047">Horinouchi and others 2005</xref>; <xref ref-type="bibr" rid="bibr95-1073858411419047">Nikonenko and others 2006</xref>). Several studies have shown a correlation between IgCAM expression level and axon regeneration into a regeneration-permissive peripheral nerve segment grafted into the CNS. Retinal ganglion cells and nigrostriatal and cholinergic neostriatal neurons express relatively high levels of L1 (and GAP-43) and are able to regenerate axons along the graft without L1 up-regulation (<xref ref-type="bibr" rid="bibr11-1073858411419047">Becker and others 2001</xref>; <xref ref-type="bibr" rid="bibr69-1073858411419047">Jung and others 1997</xref>; <xref ref-type="bibr" rid="bibr116-1073858411419047">Woolhead and others 1998</xref>). Neurons in the thalamic reticular nucleus express low levels of L1 and CHL1 but are capable of up-regulating these proteins and also successfully regrow into the graft (<xref ref-type="bibr" rid="bibr24-1073858411419047">Chaisuksunt, Campbell, and others 2000</xref>; <xref ref-type="bibr" rid="bibr121-1073858411419047">Zhang Y and others 1995</xref>). Cerebellar deep nucleus neurons and precerebellar brainstem neurons also show a substantial capacity of axon regeneration accompanied by increased expression of L1, CHL1, and GAP-43 (<xref ref-type="bibr" rid="bibr25-1073858411419047">Chaisuksunt, Zhang, and others 2000</xref>). In a mechanistic experiment, Y. <xref ref-type="bibr" rid="bibr120-1073858411419047">Zhang and others (2005)</xref> demonstrated that Purkinje cells, which do not express or up-regulate L1, CHL1, or GAP-43 and do not regenerate into grafts (<xref ref-type="bibr" rid="bibr25-1073858411419047">Chaisuksunt, Zhang, and others 2000</xref>), show remarkable axon regrowth when both L1 and GAP-43 are transgenically expressed in these cells. In line with the latter finding are observations in zebrafish showing that 1) the expression of L1.1, a homolog of mammalian L1, is increased after spinal cord injury in successfully regenerating descending axons but not in ascending projections that fail to regenerate (<xref ref-type="bibr" rid="bibr12-1073858411419047">Becker and others 2005</xref>) and 2) morpholino-mediated reduction of L1.1 expression in descending neurons leads to deficient axon regrowth and functional recovery (<xref ref-type="bibr" rid="bibr13-1073858411419047">Becker and others 2004</xref>). Without peripheral nerve grafting, however, axotomized mammalian neurons cannot regenerate their axons and, similar to poorly regenerating neurons in zebrafish, fail to up-regulate IgCAM expression (<xref ref-type="bibr" rid="bibr67-1073858411419047">Jucker and others 1996</xref>; <xref ref-type="bibr" rid="bibr87-1073858411419047">Mason and others 2003</xref>). The overall conclusion is that IgCAMs, most notably L1 in conjunction with its direct and indirect (NCAM) interaction partner GAP-43, are required for regeneration of injured CNS axons. We consider the failure of neurons to recapitulate the developmental growth-associated pattern of IgCAM expression a major limitation in adult neural repair and, therefore, expect them to be promising therapeutic targets in humans similar to what we have found them to be in rodents.</p>
</sec>
<sec id="section4-1073858411419047">
<title>IgCAMs as Extrinsic Inhibitors of Axonal Regeneration in the CNS</title>
<p>Numerous molecules with axon growth-inhibitory potential have been identified in vitro and shown to be expressed in the intact and injured CNS: for instance, myelin-associated inhibitors (Nogo-A, MAG, and the oligodendrocyte myelin glycoprotein, OMpg), guidance molecules (semaphorins, ephrins, netrins), and extracellular matrix molecules (chondroitin sulfate proteoglycans and tenascin-R, among others) (<xref ref-type="bibr" rid="bibr1-1073858411419047">Apostolova and others 2006</xref>; <xref ref-type="bibr" rid="bibr10-1073858411419047">Becker and Becker 2007b</xref>; <xref ref-type="bibr" rid="bibr47-1073858411419047">Fawcett 2009</xref>; <xref ref-type="bibr" rid="bibr54-1073858411419047">Giger and others 2010</xref>; <xref ref-type="bibr" rid="bibr80-1073858411419047">Loers and Schachner 2007</xref>). Clear evidence for a substantial contribution to poor regeneration and recovery after CNS injury exists for extracellular matrix molecules (<xref ref-type="bibr" rid="bibr47-1073858411419047">Fawcett 2009</xref>). Despite considerable efforts to understand the functions of the myelin-associated proteins, their roles in vivo remain controversial (<xref ref-type="bibr" rid="bibr54-1073858411419047">Giger and others 2010</xref>). A typical example for a controversy between expected and confirmed in vivo functions is the IgSF member MAG, the first discovered myelin neurite outgrowth-inhibiting molecule of the IgSF. MAG is expressed on the cell surface of oligodendrocytes during myelination and maintained at the periaxonal surface of compact myelin during adulthood (<xref ref-type="bibr" rid="bibr8-1073858411419047">Bartsch and others 1989</xref>). Its direct opposition to and, thus, opportunity for direct interactions with the axonal surface and the finding that MAG inhibits neurite outgrowth of early postnatal cerebellar neurons (<xref ref-type="bibr" rid="bibr49-1073858411419047">Filbin 2003</xref>) have suggested an axon growth inhibitory function of MAG in vivo. However, experiments using MAG-deficient versus wild-type mice showed that MAG deficiency did not influence the extent of axonal regrowth in the lesioned optic nerve and corticospinal tract (<xref ref-type="bibr" rid="bibr7-1073858411419047">Bartsch and others 1995</xref>). This finding can be interpreted as an indication of redundancy in myelin-associated protein signaling rather than lack of function. Each of the three myelin-associated proteins—MAG, Nogo-66 (a Nogo-A domain), and OMgp—signals growth cone collapse and axon growth inhibition in vitro via two common receptors, the well-known GPI-anchored Nogo-66 receptor (NgR1) and the recently identified receptor PirB (paired immunoglobulin-like receptor B), an IgSF member (<xref ref-type="bibr" rid="bibr2-1073858411419047">Atwal and others 2008</xref>). However, this redundancy hypothesis has not yet been confirmed. On the contrary, mice deficient in the expression of NgR1 (<xref ref-type="bibr" rid="bibr72-1073858411419047">Kim JE and others 2004</xref>), PirB (<xref ref-type="bibr" rid="bibr94-1073858411419047">Nakamura and others 2011</xref>; <xref ref-type="bibr" rid="bibr96-1073858411419047">Omoto and others 2010</xref>), or all three ligands of these receptors (<xref ref-type="bibr" rid="bibr78-1073858411419047">Lee and others 2010</xref>) failed to show prominent effects on axon regeneration and functional recovery after CNS trauma.</p>
<p>In contrast to MAG, the abilities of CHL1 to promote neurite outgrowth, neuronal migration, and survival in vitro had suggested that CHL1 promotes CNS regeneration. Recent work, however, revealed that functional recovery after compression of the thoracic spinal cord is more pronounced in CHL1-deficient mice than in wild-type littermates (<xref ref-type="bibr" rid="bibr66-1073858411419047">Jakovcevski, Wu, and others 2007</xref>). Worse recovery in wild-type mice correlated with restricted regrowth of monaminergic axons in the distal (lumbar) spinal cord and was likely related to early and persistent up-regulation of CHL1 expression in glial fibrillary acidic protein (GFAP)–positive astrocytes (reactive astrocytes; see also the following section) at the lesion site (<xref ref-type="fig" rid="fig2-1073858411419047">Fig. 2</xref>). Both in the intact spinal cord and in cultured astrocytes, enhanced expression of CHL1 and GFAP was induced by application of basic fibroblast growth factor (FGF). This up-regulation was abolished by inhibitors of the FGF receptor-dependent ERK, CaMKII, and PI3K signaling pathways. Most important, in homo- and heterogenotypic co-cultures of neurons and astrocytes, reduced neurite outgrowth was observed only if CHL1 was simultaneously present on both cell types. These findings suggest that CHL1 is a glial scar component that restricts posttraumatic axonal growth by homophilic binding mechanisms. Again cautioning against an easy extrapolation of observations from in vitro studies is the finding that CHL1, when substrate coated to measure neurite outgrowth in culture, promotes neurite outgrowth of wild-type neurons (<xref ref-type="bibr" rid="bibr31-1073858411419047">Chen S and others 1999</xref>), although in vitro studies have been successfully used as first indicators of at least some functions of IgSF molecules.</p>
<fig id="fig2-1073858411419047" position="float">
<label>Figure 2.</label>
<caption>
<p>CHL1 expression in the injured mouse spinal cord. (<italic>A–B</italic>) Double immunofluorescence on a parasagittal section for CHL1 (red) and fibronectin (green) at the lesion site six weeks after compression spinal cord injury in a C57BL6/J mouse. Scale bar: <italic>A</italic>, 100 µm; <italic>B</italic>, 20 µm. (<italic>C</italic>) Immunoblot analysis of CHL1 expression at the lesion site at different time points after injury. <italic>Top:</italic> representative immunoblot for CHL1 (180-kDa band) and the loading control, GAPDH (glyceraldehyde 3-phosphate dehydrogenase). <italic>Bottom:</italic> CHL1 expression levels, as estimated by optical density measurements, in the intact spinal cords (set to 100%) and one day (d) to eight weeks (w) after injury as percentage of intact. Mean + SEM values (*<italic>P</italic> &lt; .05 compared with intact, analysis of variance with Dunnett’s post hoc test; n = 5 mice per time point). Adapted from <xref ref-type="bibr" rid="bibr66-1073858411419047">Jakovcevski, Wu, and others (2007)</xref>.</p>
</caption>
<graphic xlink:href="10.1177_1073858411419047-fig2.tif"/>
</fig>
</sec>
<sec id="section5-1073858411419047">
<title>IgCAMs Render Permissive Properties to the Glial Scar</title>
<p>Reactive astrogliosis is one of the prominent responses of the CNS to various insults (<xref ref-type="bibr" rid="bibr109-1073858411419047">Sofroniew and Vinters 2010</xref>). In its most severe form seen after traumatic injuries or infarcts, astrogliosis is characterized by alterations in molecular expression patterns (e.g., up-regulation of GFAP), cell hypertrophy (enlargement of the cell body and processes), and proliferation (replication), leading to local accumulation of astrocytes and formation of a glial scar. A characteristic feature of the glial scar is its dense extracellular matrix produced by reactive astrocytes in association with other cell types such as fibromeningial and Schwann cells after traumatic spinal cord injury (SCI). The traditional view of the glial scar is that it represents an impermeable barrier for axon growth and cell migration. Indeed, inhibitory molecules such as chondroitin sulfate proteoglycans, tenascin-R, semaphorin-3A, ephrin-B2, slit proteins, and CHL1 are highly enriched in the glial scar (<xref ref-type="bibr" rid="bibr50-1073858411419047">Fitch and Silver 2008</xref>; <xref ref-type="bibr" rid="bibr54-1073858411419047">Giger and others 2010</xref>; <xref ref-type="bibr" rid="bibr66-1073858411419047">Jakovcevski, Wu, and others 2007</xref>). However, the scar contains also axon growth– and cell migration–promoting IgCAMs, such as PSA-NCAM, which is expressed by astrocytes after SCI. L1 is expressed by Schwann cells that invade the injured spinal cord while reverting to more immature features when their myelin undergoes Wallerian degeneration due to loss of axonal support. With time after injury, the chronic CNS glial scar becomes more permissive as the expression of chondroitin sulfate proteoglycans and myelin-associated inhibitors is decreased and PSA-NCAM expression is increased (<xref ref-type="bibr" rid="bibr20-1073858411419047">Camand and others 2004</xref>; <xref ref-type="bibr" rid="bibr42-1073858411419047">Dusart and others 1999</xref>). This type of IgCAM expression promotes the ingrowth of axons into the scar. If the scar is enriched in PSA-NCAM by overexpression in astrocytes ( <xref ref-type="bibr" rid="bibr45-1073858411419047">El Maarouf and others 2006</xref>) or in L1 by infusion of a soluble L1 fragment presenting the extracellular domain of L1 (<xref ref-type="bibr" rid="bibr100-1073858411419047">Roonprapunt and others 2003</xref>), axon regrowth across the scar, even of regeneration-refractory axons such as the corticospinal ones, is significantly enhanced. These results show that the glial scar is not exclusively impermeable to regrowing axons, indicating another promising target for therapeutic interventions.</p>
</sec>
<sec id="section6-1073858411419047">
<title>IgCAMs Are Implicated In Injury-Induced CNS Plasticity</title>
<p>Although true regeneration in the sense of regrowth of injured axons beyond the lesion site and target reinnervation does not occur to a substantial degree after CNS injury, plasticity by spared neurons is apparently pronounced. The current understanding of this phenomenon is limited, but a few studies have indicated a remarkable extent of remodeling after unilateral spinal cord injuries (dorsal or lateral hemisections). Injured corticospinal tract axons form proximal collateral sprouts that establish contacts with long-projecting propriospinal (spinal cord–intrinsic) neurons and thus regain functional connections with lumbar motoneurons (<xref ref-type="bibr" rid="bibr6-1073858411419047">Bareyre and others 2004</xref>). Injury-induced sprouting into the distal spinal cord has also been documented for spared reticulospinal axons, projections responsible for initiation of walking (<xref ref-type="bibr" rid="bibr4-1073858411419047">Ballermann and Fouad 2006</xref>). Also, it has been shown that reorganized propriospinal relay connections bypassing sites of injury are able to mediate spontaneous functional recovery and supraspinal control of stepping after interruption of long descending pathways (<xref ref-type="bibr" rid="bibr33-1073858411419047">Courtine and others 2008</xref>). Axon sprouting and establishment of novel connections also occur in peri-infarct and connected cortical areas and correlate with functional recovery after stroke (<xref ref-type="bibr" rid="bibr23-1073858411419047">Carmichael 2006</xref>). Considering the developmental roles of IgCAMs, it can be expected that they are essentially involved in plasticity after CNS injury, and several studies have provided evidence in support of this notion. L1 expression on sprouting axons has been observed after dentate gyrus deafferentation and fimbria-fornix lesions (<xref ref-type="bibr" rid="bibr3-1073858411419047">Aubert and others 1998</xref>; <xref ref-type="bibr" rid="bibr67-1073858411419047">Jucker and others 1996</xref>; <xref ref-type="bibr" rid="bibr110-1073858411419047">Styren and others 1995</xref>). Transient up-regulation of PSA-NCAM expression in astrocytes and neurons—and thus an increase in the permissiveness of the local environment—occurs in areas of reactive sprouting after different experimental lesions, including transient global ischemia, fluid percussion injury, and dentate gyrus deafferentation (<xref ref-type="bibr" rid="bibr3-1073858411419047">Aubert and others 1998</xref>; <xref ref-type="bibr" rid="bibr46-1073858411419047">Emery and others 2000</xref>; <xref ref-type="bibr" rid="bibr51-1073858411419047">Fox and others 2001</xref>; <xref ref-type="bibr" rid="bibr68-1073858411419047">Jucker and others 1995</xref>; <xref ref-type="bibr" rid="bibr110-1073858411419047">Styren and others 1995</xref>). Even remote responses to injury such as structural alterations in synapses in the motor cortex after SCI are associated with increased PSA-NCAM expression (<xref ref-type="bibr" rid="bibr71-1073858411419047">Kim BG and others 2006</xref>). Furthermore, NCAM-deficient mice recover less efficiently than wild-type mice after focal lesion of the barrel cortex, and this impairment has been related to restricted remodeling of intact circuitries surrounding the lesion (<xref ref-type="bibr" rid="bibr113-1073858411419047">Troncoso and others 2004</xref>). Not least, the finding of a differential impact on lumbar motoneuron perisomatic coverage after SCI in CHL1-deficient and wild-type mice provides evidence for the importance of IgCAMs in synaptic remodeling (<xref ref-type="bibr" rid="bibr66-1073858411419047">Jakovcevski, Wu, and others 2007</xref>). Apart from structural remodeling, IgCAMs regulate the efficacy of synaptic transmission (<xref ref-type="bibr" rid="bibr40-1073858411419047">Dityatev and others 2008</xref>). It is therefore likely that they are implicated in changes of synaptic transmission (facilitation, long-term potentiation) associated with adaptive and maladaptive responses to CNS lesions (<xref ref-type="bibr" rid="bibr37-1073858411419047">Descalzi and others 2009</xref>; <xref ref-type="bibr" rid="bibr39-1073858411419047">Di Filippo and others 2008</xref>). Future research on the involvement of IgCAMs in plasticity will be of major importance for understanding the mechanisms promoting and restricting recovery in the injured brain.</p>
<p>Development of neuropathic pain is a common complication of SCI and peripheral nerve injury likely associated with maladaptive synaptic transmission (<xref ref-type="bibr" rid="bibr57-1073858411419047">Gwak and Hulsebosch 2011</xref>) and sprouting of small-diameter nociceptive (calcitonin gene-related peptide, CGRP) expressing axons in the dorsal horn of the spinal cord (<xref ref-type="bibr" rid="bibr28-1073858411419047">Chaudhry and others 2006</xref>). Several studies have linked this spouting to L1 expression in CGRP-positive axons. After SCI, reduction of CGRP-positive axon growth has been observed in L1-deficient compared with wild-type mice (<xref ref-type="bibr" rid="bibr38-1073858411419047">Deumens and others 2007</xref>; <xref ref-type="bibr" rid="bibr63-1073858411419047">Hoschouer and others 2009</xref>). Thermal hyperalgesia after SCI develops in L1-deficient mice, but it becomes more attenuated with time compared with wild-type mice (<xref ref-type="bibr" rid="bibr63-1073858411419047">Hoschouer and others 2009</xref>). An increase in L1-positive axons and attenuation of mechanical allodynia and thermal hyperalgesia after intrathecal application of the L1 antibody have been reported after sciatic nerve transection in rats (<xref ref-type="bibr" rid="bibr118-1073858411419047">Yamanaka and others 2007</xref>). However, sprouting of CGRP-positive axons in the dorsal horn after dorsal rhizotomy is similar in L1-deficient and wild-type mice (<xref ref-type="bibr" rid="bibr102-1073858411419047">Runyan and others 2007</xref>). And interestingly, CGRP-positive axonal sprouting induced by nerve growth factor overexpression in astrocytes after SCI is significantly reduced by co-expression of L1, possibly via a neuropilin-1/semaphorin-3A signaling mechanism (<xref ref-type="bibr" rid="bibr28-1073858411419047">Chaudhry and others 2006</xref>). This finding is important regarding therapeutic approaches using L1 overexpression in the injured spinal cord, as it is for other neurite outgrowth-promoting molecules. Even if L1 contributes to development of neuropathic pain under certain conditions, transgenic expression or infusion of L1 is likely to suppress rather than enhance abnormal pain sensitivity. That overexpression of regeneration-promoting factors must not necessarily lead to allodynia and hyperalgesia has been shown for a combinatorial treatment with transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors (<xref ref-type="bibr" rid="bibr70-1073858411419047">Karimi-Abdolrezaee and others 2010</xref>). In contrast to L1, NCAM signaling has been proposed to play a critical role in the analgesic effect of glial cell–derived neurotrophic factor (GDNF) in neuropathic pain (<xref ref-type="bibr" rid="bibr103-1073858411419047">Sakai and others 2008</xref>). Further studies on the influence of IgCAMs on neuropathic pain are of major clinical relevance considering that treatment of this complication in humans is extremely difficult (<xref ref-type="bibr" rid="bibr115-1073858411419047">Woolf and Mannion 1999</xref>).</p>
</sec>
<sec id="section7-1073858411419047">
<title>Neuroprotection by IgCAMs</title>
<p>The evidence for neuroprotective effects of IgCAMs in vivo is less abundant than the in vitro evidence, yet it is of significant importance regarding the substantial impact of secondary damage and cell death on the severity and outcome of CNS lesions. Neuroprotective functions of IgCAMs or related glycans have been indicated by findings in several injury models. Enzymatic removal of PSA results in loss of retinal ganglion cells in the intact adult retina of mice, and this loss is significantly exaggerated after optic nerve transection (<xref ref-type="bibr" rid="bibr93-1073858411419047">Murphy and others 2009</xref>). Enhanced apoptosis and more severe impairment after SCI have been observed in NCAM-deficient compared with wild-type mice (<xref ref-type="bibr" rid="bibr119-1073858411419047">Zhang S and others 2010</xref>). PSA-NCAM is up-regulated, in conjunction with heat shock protein 70 (HSP70), after hyperthermia, a treatment conferring resistance to kainate-induced neurodegeneration, and the neuroprotective effect of hyperthermia is abolished in the absence of PSA (<xref ref-type="bibr" rid="bibr43-1073858411419047">Duveau and others 2007</xref>). In a mouse model of temporal lobe epilepsy, PSA-NCAM is up-regulated in the morphologically intact hippocampus contralateral to the site of kainate injection, and this expression enables survival of principal neurons via GDNF signaling (<xref ref-type="bibr" rid="bibr44-1073858411419047">Duveau and Fritschy 2010</xref>). Neuroprotective effects have been reported after basic fibroblast growth factor (FGF-2) delivery to the injured spinal cord (<xref ref-type="bibr" rid="bibr91-1073858411419047">Meijs and others 2004</xref>; <xref ref-type="bibr" rid="bibr111-1073858411419047">Teng and others 1999</xref>), and it is plausible to assume that these effects are mediated via NCAM-FGFR signaling. Important for cell-based therapies, L1 overexpression in stem cells significantly improves their survival, as compared with nontransfected cells, after transplantation in a mouse model of Parkinson disease and after SCI (<xref ref-type="bibr" rid="bibr29-1073858411419047">Chen J and others 2005</xref>; <xref ref-type="bibr" rid="bibr34-1073858411419047">Cui and others 2010</xref>). Finally, interesting and promising from a clinical point of view is also the finding that centrally or systemically applied antibodies against MAG significantly reduce lesion volume and improve motor function after middle cerebral artery occlusion (<xref ref-type="bibr" rid="bibr64-1073858411419047">Irving and others 2005</xref>).</p>
</sec>
<sec id="section8-1073858411419047">
<title>Differential Modulation of PNS Regeneration by IgCAMs</title>
<p>PSA-NCAM is abundantly expressed in PNS axons and neurons as well as Schwann cells during embryonic development and up-regulated in these cell types after nerve injury in the adult rodent (<xref ref-type="bibr" rid="bibr84-1073858411419047">Martini 1994</xref>; <xref ref-type="bibr" rid="bibr85-1073858411419047">Martini and Schachner 1988</xref>). Expression of NCAM on both regenerating axons and Schwann cells has suggested that it fosters regeneration. In line with this notion is the finding that application of neutralizing antibodies against NCAM causes a delay in but does not compromise endplate reinnervation after gluteal nerve injury in mice (<xref ref-type="bibr" rid="bibr76-1073858411419047">Langenfeld-Oster and others 1994</xref>). Constitutive ablation of NCAM in mice does not lead to an apparent delay in reinnervation, as indicated by similar rates of functional recovery within the first two months after sciatic nerve crush in NCAM-deficient and wild-type mice (<xref ref-type="bibr" rid="bibr48-1073858411419047">Fey and others 2010</xref>). Initial endplate reinnervation also proceeds normally in the NCAM-deficient mouse, but this innervation becomes compromised with time after injury due to instability of the newly formed endplates, leading, by three months after injury, to deficits in neurotransmitter release, withdrawal of axons from reinnervated endplates, and loss of contractile muscle force (<xref ref-type="bibr" rid="bibr32-1073858411419047">Chipman and others 2010</xref>). As a consequence, motor function at three months after injury is worse in NCAM-deficient than in wild-type mice (<xref ref-type="bibr" rid="bibr48-1073858411419047">Fey and others 2010</xref>). These findings indicate that NCAM expression is required for long-term stability of reinnervated endplates. In addition, recent work has suggested that increased PSA-NCAM expression after femoral nerve injury is necessary for preferential targeting of regenerating motor axons to skeletal muscle as opposed to skin (<xref ref-type="bibr" rid="bibr53-1073858411419047">Franz and others 2005</xref>, <xref ref-type="bibr" rid="bibr52-1073858411419047">2008</xref>), a phenomenon known as preferential motor reinnervation (<xref ref-type="bibr" rid="bibr18-1073858411419047">Brushart 1988</xref>).</p>
<p>Similar to NCAM, L1 is expressed in axons and Schwann cells during embryonic and early postnatal development and up-regulated after nerve injury (<xref ref-type="bibr" rid="bibr85-1073858411419047">Martini and Schachner 1988</xref>; <xref ref-type="bibr" rid="bibr86-1073858411419047">Martini and others 1994</xref>), suggesting a beneficial role in regeneration in the adult PNS. Contrary to this hypothesis, regeneration experiments using the femoral nerve injury paradigm in mice revealed better functional recovery in L1-deficient mice compared with wild-type littermates (<xref ref-type="bibr" rid="bibr55-1073858411419047">Guseva and others 2009</xref>). Improved regeneration in L1-deficient mice was also indicated by attenuated posttraumatic loss of motoneurons, enhanced precision of motor reinnervation, larger cell bodies of regenerated motoneurons, and diminished loss of inhibitory synaptic input to motoneurons. A possible explanation of the observed counterintuitive effects is that Schwann cell proliferation is strongly augmented in L1-deficient versus wild-type mice (<xref ref-type="fig" rid="fig3-1073858411419047">Fig. 3</xref>), indicative of enhanced production of beneficial cytokines. Thus, it appears that L1 negatively regulates Schwann cell proliferation after nerve damage, which in turn restricts functional recovery by limiting the trophic support for regenerating motoneurons.</p>
<fig id="fig3-1073858411419047" position="float">
<label>Figure 3.</label>
<caption>
<p>Schwann cell proliferation in injured femoral nerves of L1-deficient (L1y/–) male mice and wild-type (L1y/+) male littermates. Longitudinal cryostat sections of 5 µm thickness from distal stumps of transected femoral nerves of L1y/– (<italic>A–F</italic>) and L1y/+ mice (<italic>A</italic>′<italic>–F</italic>′) dissected three to seven days after injury. Staining for the Schwann cell marker S-100 (<italic>A–C</italic>′) reveals higher numbers of S-100-positive cells in L1y/– mice (<italic>A–C</italic>) than in L1y/+ littermates (<italic>A</italic>′<italic>–C</italic>′). Staining of sections serial to those shown in panels <italic>A–C</italic>′ with an antibody against the proliferation marker Ki67 (<italic>D–F</italic>′) shows also higher numbers of proliferating cells in L1y/– mice than in L1y/+ mice at all time points studied. Scale bars in A and D indicate 50 and 100 µm for <italic>A–C</italic>′ and <italic>D–F</italic>′, respectively. Adapted from <xref ref-type="bibr" rid="bibr55-1073858411419047">Guseva and others (2009)</xref>.</p>
</caption>
<graphic xlink:href="10.1177_1073858411419047-fig3.tif"/></fig>
<p>MAG is expressed by Schwann cells in the PNS and is down-regulated during the period of Wallerian degeneration after nerve injury (<xref ref-type="bibr" rid="bibr85-1073858411419047">Martini and Schachner 1988</xref>). If Wallerian degeneration is delayed and myelin debris and thus MAG persist for a longer period in the distal stump of the injured nerve as in the C57BL/Wlds mouse, axonal regeneration is delayed, and genetic ablation of MAG in this mutant improves regeneration (<xref ref-type="bibr" rid="bibr104-1073858411419047">Schäfer and others 1996</xref>). Application of antibodies against MAG enhances the speed of axonal regrowth after sciatic nerve injury (<xref ref-type="bibr" rid="bibr112-1073858411419047">Tomita and others 2007</xref>) and accelerates preferential motor reinnervation after femoral nerve injury in mice (<xref ref-type="bibr" rid="bibr88-1073858411419047">Mears and others 2003</xref>). These findings are consistent with an inhibitory role of MAG in peripheral nerve regeneration. Interestingly, however, application of an MAG-Fc fragment, but not MAG antibody, to the injured mouse sciatic nerve leads to significantly improved functional outcome (<xref ref-type="bibr" rid="bibr112-1073858411419047">Tomita and others 2007</xref>). This positive effect of MAG has been attributed to inhibition of axonal branching at the lesion site via activation of RhoA and subsequent improvement of the precision of target reinnervation.</p>
<p>In intact adult rodents, CHL1 is expressed at higher levels in peripheral neurons than L1 (<xref ref-type="bibr" rid="bibr66-1073858411419047">Jakovcevski, Wu, and others 2007</xref>), and its expression is up-regulated in neurons and Schwann cells after nerve injury (<xref ref-type="bibr" rid="bibr122-1073858411419047">Zhang Y and others 2000</xref>). The functional role of this expression pattern is currently unknown. It will be interesting to study regeneration in the PNS of CHL1-deficient mice, especially considering the unexpected findings in L1-deficient mice described above.</p>
</sec>
<sec id="section9-1073858411419047">
<title>IgCAMs and Myelination in the Central and Peripheral Nervous System</title>
<p>Poor remyelination of axons after CNS and PNS injuries is considered a factor contributing to limited functional recovery (<xref ref-type="bibr" rid="bibr58-1073858411419047">Hildebrand and others 1985</xref>; <xref ref-type="bibr" rid="bibr117-1073858411419047">Wu and Ren 2009</xref>). The role of IgCAMs in remyelination is still not well understood. Studies of the developing nervous system have suggested that L1 and MAG contribute to the success of myelination at its early stages (<xref ref-type="bibr" rid="bibr86-1073858411419047">Martini and others 1994</xref>) and that down-regulation of PSA-NCAM is required for myelination (<xref ref-type="bibr" rid="bibr65-1073858411419047">Jakovcevski, Mo, and others 2007</xref>; <xref ref-type="bibr" rid="bibr84-1073858411419047">Martini 1994</xref>). Analyses of myelin in NCAM- and MAG-deficient mice revealed, however, minor deficits in compact myelin only if, in addition, the myelin protein P0 was genetically deleted (<xref ref-type="bibr" rid="bibr22-1073858411419047">Carenini and others 1999</xref>). Enzymatic removal in PSA in the postnatal optic nerve of mice leads to only a transient increase in the number of myelinated internodes (<xref ref-type="bibr" rid="bibr26-1073858411419047">Charles and others 2000</xref>). Expression of PSA-NCAM on demyelinated CNS axons has been proposed to inhibit remyelination in multiple sclerosis patients (<xref ref-type="bibr" rid="bibr27-1073858411419047">Charles and others 2002</xref>), but experimental evidence has yet to support this notion. In contrast to the expected inhibitory role of PSA on myelination, application of a functional peptide mimic of PSA to the injured femoral nerve or injured spinal cord of adult mice led to a pronounced improvement of axonal myelination and functional recovery (<xref ref-type="bibr" rid="bibr90-1073858411419047">Mehanna and others 2009</xref>, <xref ref-type="bibr" rid="bibr89-1073858411419047">2010</xref>). Although the mechanisms underlying these effects are currently unclear, the results indicate that PSA signaling is of functional importance in the injured CNS and PNS of mammals.</p>
<p>In peripheral nerves of adult L1-deficient mice, myelination is normal and remyelination after nerve injury is apparently not impaired (<xref ref-type="bibr" rid="bibr36-1073858411419047">Dahme and others 1997</xref>; <xref ref-type="bibr" rid="bibr55-1073858411419047">Guseva and others 2009</xref>). However, if L1 is transgenically overexpressed in adult mice under the control of the neuron-specific Thy-1 promoter, myelination of regenerated axons after femoral nerve injury is improved compared with wild-type mice (<xref ref-type="bibr" rid="bibr56-1073858411419047">Guseva and others 2011</xref>). This finding shows for the first time that L1 plays an important role in myelination in vivo and indicates a potential target of L1-based therapies for nervous system repair.</p>
</sec>
<sec id="section10-1073858411419047">
<title>Therapeutic Approaches Using IgCAMs and Their Associated Glycans</title>
<p>On the basis of knowledge acquired in experiments in vitro and in vivo on functional roles of IgCAMs in regeneration, researchers have devised and tested various therapeutic approaches in different animal models in recent years. One major finding of these therapeutic trials is that enrichment of the regeneration-hostile adult CNS environment with L1 is beneficial for repair of the CNS. After SCI, improvement of function associated with enhanced axon regeneration has been achieved by infusion of a soluble L1-Fc fragment in rats (<xref ref-type="bibr" rid="bibr100-1073858411419047">Roonprapunt and others 2003</xref>) and overexpression of L1 in neurons and glial cells using an adeno-associated viral construct in mice (<xref ref-type="bibr" rid="bibr30-1073858411419047">Chen J and others 2007</xref>). L1 overexpression in stem cells promotes their survival, differentiation, and migration after transplantation in vivo and increases their therapeutic potential in models of Huntington and Parkinson diseases and spinal cord injury in mice (<xref ref-type="bibr" rid="bibr14-1073858411419047">Bernreuther and others 2006</xref>; <xref ref-type="bibr" rid="bibr29-1073858411419047">Chen J and others 2005</xref>; <xref ref-type="bibr" rid="bibr34-1073858411419047">Cui and others 2010</xref>; <xref ref-type="bibr" rid="bibr97-1073858411419047">Ourednik and others 2009</xref>). Similar to L1, virally induced overexpression of PSA in the damaged CNS promotes axon growth ( <xref ref-type="bibr" rid="bibr45-1073858411419047">El Maarouf and others 2006</xref>), and application of PSA peptide mimetics improves the anatomical and functional outcome after SCI in mice (<xref ref-type="bibr" rid="bibr83-1073858411419047">Marino and others 2009</xref>; <xref ref-type="bibr" rid="bibr89-1073858411419047">Mehanna and others 2010</xref>). Overexpression of L1 or PSA in transplanted Schwann cells leads to better, as compared with nontransfected cells, remyelination and functional recovery after SCI in mice (<xref ref-type="bibr" rid="bibr77-1073858411419047">Lavdas and others 2010</xref>; <xref ref-type="bibr" rid="bibr98-1073858411419047">Papastefanaki and others 2007</xref>). PSA and an NCAM-derived peptide have been shown to be beneficial for CNS repair by facilitating cognitive and motor recovery and diminishing neurodegeneration after traumatic brain injury in rats (<xref ref-type="bibr" rid="bibr74-1073858411419047">Klementiev and others 2008</xref>). Finally, we should mention that peptide mimetics of PSA and HNK-1, a glycan shared by NCAM, L1, CHL1, MAG, and other recognition molecules, such as tenascin-C, are effective in promoting functional recovery after peripheral nerve injury in adult mice (<xref ref-type="bibr" rid="bibr90-1073858411419047">Mehanna and others 2009</xref>; <xref ref-type="bibr" rid="bibr108-1073858411419047">Simova and others 2006</xref>). The combined results unequivocally indicate beneficial functions of IgCAMs in neural repair and point to clinically feasible approaches to improve functional recovery after injuries in the PNS and CNS.</p>
</sec>
<sec id="section11-1073858411419047">
<title>Concluding Remarks</title>
<p>The understanding of molecular and cellular phenomena determining the responses of the nervous system to injury and limiting restoration of function has significantly increased in recent years. It is now accepted that several IgCAMs are major players in the complexity of events associated with neural repair, including axonal regrowth, remyelination, and synaptic plasticity. Based on the knowledge of how these molecules restrict or promote regeneration, the design of promising therapeutic strategies for humans has emerged. However, our major knowledge of the functional roles of IgCAMs is restricted to only a few molecules and areas of research, and investigations on neural plasticity after injury and interactions of IgCAMs with the immune system have not yet received enough attention. Addressing these issues is a major challenge for future research and promise for further progress.</p>
</sec>
</body>
<back>
<ack><p>The authors are grateful to Gabriele Loers for comments on the manuscript.</p></ack>
<fn-group>
<fn fn-type="other">
<label>Note</label>
<p>The literature reviewed here includes papers published until January 2011.</p>
</fn>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interests with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Financial Disclosure/Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Apostolova</surname><given-names>I</given-names></name>
<name><surname>Irintchev</surname><given-names>A</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>2006</year>. <article-title>Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice</article-title>. <source>J Neurosci</source> <volume>26</volume>(<issue>30</issue>):<fpage>7849</fpage>–<lpage>59</lpage>.</citation>
</ref>
<ref id="bibr2-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Atwal</surname><given-names>JK</given-names></name>
<name><surname>Pinkston-Gosse</surname><given-names>J</given-names></name>
<name><surname>Syken</surname><given-names>J</given-names></name>
<name><surname>Stawicki</surname><given-names>S</given-names></name>
<name><surname>Wu</surname><given-names>Y</given-names></name>
<name><surname>Shatz</surname><given-names>C</given-names></name>
</person-group>, and others. <year>2008</year>. <article-title>PirB is a functional receptor formyelin inhibitors of axonal regeneration</article-title>. <source>Science</source> <volume>322</volume>(<issue>5903</issue>):<fpage>967</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr3-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aubert</surname><given-names>I</given-names></name>
<name><surname>Ridet</surname><given-names>JL</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Rougon</surname><given-names>G</given-names></name>
<name><surname>Gage</surname><given-names>FH</given-names></name>
</person-group>. <year>1998</year>. <article-title>Expression of L1 and PSA during sprouting and regeneration in the adult hippocampal formation</article-title>. <source>J Comp Neurol</source> <volume>399</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr4-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ballermann</surname><given-names>M</given-names></name>
<name><surname>Fouad</surname><given-names>K</given-names></name>
</person-group>. <year>2006</year>. <article-title>Spontaneous locomotor recovery in spinal cord injured rats is accompanied by anatomical plasticity of reticulospinal fibers</article-title>. <source>Eur J Neurosci</source> <volume>23</volume>(<issue>8</issue>):<fpage>1988</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr5-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barclay</surname><given-names>AN</given-names></name>
</person-group>. <year>2003</year>. <article-title>Membrane proteins with immunoglobulin-like domains—a master superfamily of interaction molecules</article-title>. <source>Semin Immunol</source> <volume>15</volume>(<issue>4</issue>):<fpage>215</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr6-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bareyre</surname><given-names>FM</given-names></name>
<name><surname>Kerschensteiner</surname><given-names>M</given-names></name>
<name><surname>Raineteau</surname><given-names>O</given-names></name>
<name><surname>Mettenleiter</surname><given-names>TC</given-names></name>
<name><surname>Weinmann</surname><given-names>O</given-names></name>
<name><surname>Schwab</surname><given-names>ME</given-names></name>
</person-group>. <year>2004</year>. <article-title>The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats</article-title>. <source>Nat Neurosci</source> <volume>7</volume>(<issue>3</issue>):<fpage>269</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr7-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bartsch</surname><given-names>U</given-names></name>
<name><surname>Bandtlow</surname><given-names>CE</given-names></name>
<name><surname>Schnell</surname><given-names>L</given-names></name>
<name><surname>Bartsch</surname><given-names>S</given-names></name>
<name><surname>Spillmann</surname><given-names>AA</given-names></name>
<name><surname>Rubin</surname><given-names>BP</given-names></name>
</person-group>, and others. <year>1995</year>. <article-title>Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS</article-title>. <source>Neuron</source> <volume>15</volume>(<issue>6</issue>):<fpage>1375</fpage>–<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr8-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bartsch</surname><given-names>U</given-names></name>
<name><surname>Kirchhoff</surname><given-names>F</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>1989</year>. <article-title>Immunohistological localization of the adhesion molecules L1, N-CAM, and MAG in the developing and adult optic nerve of mice</article-title>. <source>J Comp Neurol</source> <volume>284</volume>(<issue>3</issue>):<fpage>451</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr9-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Becker</surname><given-names>CG</given-names></name>
<name><surname>Becker</surname><given-names>T</given-names></name>
</person-group>. <year>2007a</year>. <article-title>Growth and pathfinding of regenerating axons in the optic projection of adult fish</article-title>. <source>J Neurosci Res</source> <volume>85</volume>(<issue>12</issue>):<fpage>2793</fpage>–<lpage>9</lpage></citation>
</ref>
<ref id="bibr10-1073858411419047">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Becker</surname><given-names>CG</given-names></name>
<name><surname>Becker</surname><given-names>T</given-names></name>
</person-group>. <year>2007b</year>. <source>Model organisms in spinal cord regeneration</source>. <publisher-loc>Weinheim, Germany</publisher-loc>: <publisher-name>John Wiley</publisher-name>.</citation>
</ref>
<ref id="bibr11-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Becker</surname><given-names>CG</given-names></name>
<name><surname>Becker</surname><given-names>T</given-names></name>
<name><surname>Meyer</surname><given-names>RL</given-names></name>
</person-group>. <year>2001</year>. <article-title>Increased NCAM-180 immunoreactivity and maintenance of L1 immunoreactivity in injured optic fibers of adult mice</article-title>. <source>Exp Neurol</source> <volume>169</volume>(<issue>2</issue>):<fpage>438</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr12-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Becker</surname><given-names>T</given-names></name>
<name><surname>Lieberoth</surname><given-names>BC</given-names></name>
<name><surname>Becker</surname><given-names>CG</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>2005</year>. <article-title>Differences in the regenerative response of neuronal cell populations and indications for plasticity in intraspinal neurons after spinal cord transection in adult zebrafish</article-title>. <source>Mol Cell Neurosci</source> <volume>30</volume>(<issue>2</issue>):<fpage>265</fpage>–<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr13-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Becker</surname><given-names>CG</given-names></name>
<name><surname>Lieberoth</surname><given-names>BC</given-names></name>
<name><surname>Morellini</surname><given-names>F</given-names></name>
<name><surname>Feldner</surname><given-names>J</given-names></name>
<name><surname>Becker</surname><given-names>T</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>2004</year>. <article-title>L1.1 is involved in spinal cord regeneration in adult zebrafish</article-title>. <source>J Neurosci</source> <volume>24</volume>(<issue>36</issue>):<fpage>7837</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr14-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bernreuther</surname><given-names>C</given-names></name>
<name><surname>Dihné</surname><given-names>M</given-names></name>
<name><surname>Johann</surname><given-names>V</given-names></name>
<name><surname>Schiefer</surname><given-names>J</given-names></name>
<name><surname>Cui</surname><given-names>Y</given-names></name>
<name><surname>Hargus</surname><given-names>G</given-names></name>
</person-group>, and others. <year>2006</year>. <article-title>Neural cell adhesion molecule L1-transfected embryonic stem cells promote functional recovery after excitotoxic lesion of the mouse striatum</article-title>. <source>J Neurosci</source> <volume>26</volume>(<issue>45</issue>):<fpage>11532</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr15-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blackmore</surname><given-names>M</given-names></name>
<name><surname>Letourneau</surname><given-names>PC</given-names></name>
</person-group>. <year>2006a</year>. <article-title>Changes within maturing neurons limit axonal regeneration in the developing spinal cord</article-title>. <source>J Neurobiol</source> <volume>66</volume>(<issue>4</issue>):<fpage>348</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr16-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blackmore</surname><given-names>M</given-names></name>
<name><surname>Letourneau</surname><given-names>PC</given-names></name>
</person-group>. <year>2006b</year>. <article-title>L1, beta1 integrin, and cadherins mediate axonal regeneration in the embryonic spinal cord</article-title>. <source>J Neurobiol</source> <volume>66</volume>(<issue>14</issue>):<fpage>1564</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr17-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bonfanti</surname><given-names>L</given-names></name>
</person-group>. <year>2006</year>. <article-title>PSA-NCAM in mammalian structural plasticity and neurogenesis</article-title>. <source>Prog Neurobiol</source> <volume>80</volume>(<issue>3</issue>):<fpage>129</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr18-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brushart</surname><given-names>T</given-names></name>
</person-group>. <year>1988</year>. <article-title>Preferential reinnervation of motor nerves by regenerating motor axons</article-title>. <source>J Neurosci</source> <volume>8</volume>(<issue>3</issue>):<fpage>1026</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr19-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brümmendorf</surname><given-names>T</given-names></name>
<name><surname>Rathjen</surname><given-names>FG</given-names></name>
</person-group>. <year>1996</year>. <article-title>Structure/function relationships of axon-associated adhesion receptors of the immunoglobulin superfamily</article-title>. <source>Curr Opin Neurobiol</source> <volume>6</volume>(<issue>5</issue>):<fpage>584</fpage>–<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr20-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Camand</surname><given-names>E</given-names></name>
<name><surname>Morel</surname><given-names>MP</given-names></name>
<name><surname>Faissner</surname><given-names>A</given-names></name>
<name><surname>Sotelo</surname><given-names>C</given-names></name>
<name><surname>Dusart</surname><given-names>I</given-names></name>
</person-group>. <year>2004</year>. <article-title>Long-term changes in the molecular composition of the glial scar and progressive increase of serotoninergic fibre sprouting after hemisection of the mouse spinal cord</article-title>. <source>Eur J Neurosci</source> <volume>20</volume>(<issue>5</issue>):<fpage>1161</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr21-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>DG</given-names></name>
<name><surname>Williams</surname><given-names>AF</given-names></name>
<name><surname>Bayley</surname><given-names>PM</given-names></name>
<name><surname>Reid</surname><given-names>KB</given-names></name>
</person-group>. <year>1979</year>. <article-title>Structural similarities between Thy-1 antigen from rat brain and immunoglobulin</article-title>. <source>Nature</source> <volume>282</volume>(<issue>5736</issue>):<fpage>341</fpage>–<lpage>2</lpage>.</citation>
</ref>
<ref id="bibr22-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carenini</surname><given-names>S</given-names></name>
<name><surname>Montag</surname><given-names>D</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Martini</surname><given-names>R</given-names></name>
</person-group>. <year>1999</year>. <article-title>Subtle roles of neural cell adhesion molecule and myelin-associated glycoprotein during Schwann cell spiralling in P0-deficient mice</article-title>. <source>Glia</source> <volume>27</volume>(<issue>3</issue>):<fpage>203</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr23-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carmichael</surname><given-names>ST</given-names></name>
</person-group>. <year>2006</year>. <article-title>Cellular and molecular mechanisms of neural repair after stroke: making waves</article-title>. <source>Ann Neurol</source> <volume>59</volume>(<issue>5</issue>):<fpage>735</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr24-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chaisuksunt</surname><given-names>V</given-names></name>
<name><surname>Campbell</surname><given-names>G</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Lieberman</surname><given-names>AR</given-names></name>
<name><surname>Anderson</surname><given-names>PN</given-names></name>
</person-group>. <year>2000</year>. <article-title>The cell recognition molecule CHL1 is strongly upregulated by injured and regenerating thalamic neurons</article-title>. <source>J Comp Neurol</source> <volume>425</volume>(<issue>3</issue>):<fpage>382</fpage>–<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr25-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chaisuksunt</surname><given-names>V</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Anderson</surname><given-names>PN</given-names></name>
<name><surname>Campbell</surname><given-names>G</given-names></name>
<name><surname>Vaudano</surname><given-names>E</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>, and others. <year>2000</year>. <article-title>Axonal regeneration from CNS neurons in the cerebellum and brainstem of adult rats: correlation with the patterns of expression and distribution of messenger RNAs for L1, CHL1, c-jun and growth-associated protein-43</article-title>. <source>Neuroscience</source> <volume>100</volume>(<issue>1</issue>):<fpage>87</fpage>–<lpage>108</lpage>.</citation>
</ref>
<ref id="bibr26-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Charles</surname><given-names>P</given-names></name>
<name><surname>Hernandez</surname><given-names>MP</given-names></name>
<name><surname>Stankoff</surname><given-names>B</given-names></name>
<name><surname>Aigrot</surname><given-names>MS</given-names></name>
<name><surname>Colin</surname><given-names>C</given-names></name>
<name><surname>Rougon</surname><given-names>G</given-names></name>
</person-group>, and others. <year>2000</year>. <article-title>Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>97</volume>(<issue>13</issue>):<fpage>7585</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr27-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Charles</surname><given-names>P</given-names></name>
<name><surname>Reynolds</surname><given-names>R</given-names></name>
<name><surname>Seilhean</surname><given-names>D</given-names></name>
<name><surname>Rougon</surname><given-names>G</given-names></name>
<name><surname>Aigrot</surname><given-names>MS</given-names></name>
<name><surname>Niezgoda</surname><given-names>A</given-names></name>
</person-group>, and others. <year>2002</year>. <article-title>Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?</article-title> <source>Brain</source> <volume>125</volume>(<issue>Pt 9</issue>):<fpage>1972</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr28-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chaudhry</surname><given-names>N</given-names></name>
<name><surname>de</surname><given-names>Silva U</given-names></name>
<name><surname>Smith</surname><given-names>GM</given-names></name>
</person-group>. <year>2006</year>. <article-title>Cell adhesion molecule L1 modulates nerve-growth-factor-induced CGRP-IR fiber sprouting</article-title>. <source>Exp Neurol</source> <volume>202</volume>(<issue>1</issue>):<fpage>238</fpage>–<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr29-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>J</given-names></name>
<name><surname>Bernreuther</surname><given-names>C</given-names></name>
<name><surname>Dihné</surname><given-names>M</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>2005</year>. <article-title>Cell adhesion molecule L–transfected embryonic stem cells with enhanced survival support regrowth of corticospinal tract axons in mice after spinal cord injury</article-title>. <source>J Neurotrauma</source> <volume>22</volume>(<issue>8</issue>):<fpage>896</fpage>–<lpage>906</lpage>.</citation>
</ref>
<ref id="bibr30-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>J</given-names></name>
<name><surname>Wu</surname><given-names>J</given-names></name>
<name><surname>Apostolova</surname><given-names>I</given-names></name>
<name><surname>Skup</surname><given-names>M</given-names></name>
<name><surname>Irintchev</surname><given-names>A</given-names></name>
<name><surname>Kügler</surname><given-names>S</given-names></name>
</person-group>, and others. <year>2007</year>. <article-title>Adeno-associated virus-mediated L1 expression promotes functional recovery after spinal cord injury</article-title>. <source>Brain</source> <volume>130</volume>(<issue>Pt 4</issue>):<fpage>954</fpage>–<lpage>69</lpage>.</citation>
</ref>
<ref id="bibr31-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>S</given-names></name>
<name><surname>Mantei</surname><given-names>N</given-names></name>
<name><surname>Dong</surname><given-names>L</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>1999</year>. <article-title>Prevention of neuronal cell death by neural adhesion molecules L1 and CHL1</article-title>. <source>J Neurobiol</source> <volume>38</volume>(<issue>3</issue>):<fpage>428</fpage>–<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr32-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chipman</surname><given-names>PH</given-names></name>
<name><surname>Franz</surname><given-names>CK</given-names></name>
<name><surname>Nelson</surname><given-names>A</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Rafuse</surname><given-names>VF</given-names></name>
</person-group>. <year>2010</year>. <article-title>Neural cell adhesion molecule is required for stability of reinnervated neuromuscular junctions</article-title>. <source>Eur J Neurosci</source> <volume>31</volume>(<issue>2</issue>):<fpage>238</fpage>–<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr33-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Courtine</surname><given-names>G</given-names></name>
<name><surname>Song</surname><given-names>B</given-names></name>
<name><surname>Roy</surname><given-names>RR</given-names></name>
<name><surname>Zhong</surname><given-names>H</given-names></name>
<name><surname>Herrmann</surname><given-names>JE</given-names></name>
<name><surname>Ao</surname><given-names>Y</given-names></name>
</person-group>, and others. <year>2008</year>. <article-title>Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury</article-title>. <source>Nat Med</source> <volume>14</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr34-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cui</surname><given-names>YF</given-names></name>
<name><surname>Hargus</surname><given-names>G</given-names></name>
<name><surname>Xu</surname><given-names>JC</given-names></name>
<name><surname>Schmid</surname><given-names>JS</given-names></name>
<name><surname>Shen</surname><given-names>YQ</given-names></name>
<name><surname>Glatzel</surname><given-names>M</given-names></name>
</person-group>, and others. <year>2010</year>. <article-title>Embryonic stem cell–derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice</article-title>. <source>Brain</source> <volume>133</volume>(<issue>Pt 1</issue>):<fpage>189</fpage>–<lpage>204</lpage>.</citation>
</ref>
<ref id="bibr35-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cunningham</surname><given-names>BA</given-names></name>
</person-group>. <year>1995</year>. <article-title>Cell adhesion molecules as morphoregulators</article-title>. <source>Curr Opin Cell Biol</source> <volume>7</volume>(<issue>5</issue>):<fpage>628</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr36-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dahme</surname><given-names>M</given-names></name>
<name><surname>Bartsch</surname><given-names>U</given-names></name>
<name><surname>Martini</surname><given-names>R</given-names></name>
<name><surname>Anliker</surname><given-names>B</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Mantei</surname><given-names>N</given-names></name>
</person-group>. <year>1997</year>. <article-title>Disruption of the mouse L1 gene leads to malformations of the nervous system</article-title>. <source>Nat Genet</source> <volume>17</volume>(<issue>3</issue>):<fpage>346</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr37-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Descalzi</surname><given-names>G</given-names></name>
<name><surname>Kim</surname><given-names>S</given-names></name>
<name><surname>Zhuo</surname><given-names>M</given-names></name>
</person-group>. <year>2009</year>. <article-title>Presynaptic and postsynaptic cortical mechanisms of chronic pain</article-title>. <source>Mol Neurobiol</source> <volume>40</volume>(<issue>3</issue>):<fpage>253</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr38-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Deumens</surname><given-names>R</given-names></name>
<name><surname>Lübbers</surname><given-names>M</given-names></name>
<name><surname>Jaken</surname><given-names>RJ</given-names></name>
<name><surname>Meijs</surname><given-names>MF</given-names></name>
<name><surname>Thurlings</surname><given-names>RM</given-names></name>
<name><surname>Honig</surname><given-names>WM</given-names></name>
</person-group>, and others. <year>2007</year>. <article-title>Mice lacking L1 have reduced CGRP fibre in-growth into spinal transection lesions</article-title>. <source>Neurosci Lett</source> <volume>420</volume>(<issue>3</issue>):<fpage>277</fpage>–<lpage>81</lpage>.</citation>
</ref>
<ref id="bibr39-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Di Filippo</surname><given-names>M</given-names></name>
<name><surname>Tozzi</surname><given-names>A</given-names></name>
<name><surname>Costa</surname><given-names>C</given-names></name>
<name><surname>Belcastro</surname><given-names>V</given-names></name>
<name><surname>Tantucci</surname><given-names>M</given-names></name>
<name><surname>Picconi</surname><given-names>B</given-names></name>
</person-group>, and others. <year>2008</year>. <article-title>Plasticity and repair in the post-ischemic brain</article-title>. <source>Neuropharmacology</source> <volume>55</volume>(<issue>3</issue>):<fpage>353</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr40-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dityatev</surname><given-names>A</given-names></name>
<name><surname>Bukalo</surname><given-names>O</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>2008</year>. <article-title>Modulation of synaptic transmission and plasticity by cell adhesion and repulsion molecules</article-title>. <source>Neuron Glia Biol</source> <volume>4</volume>(<issue>3</issue>):<fpage>197</fpage>–<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr41-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Doherty</surname><given-names>P</given-names></name>
<name><surname>Williams</surname><given-names>G</given-names></name>
<name><surname>Williams</surname><given-names>EJ</given-names></name>
</person-group>. <year>2000</year>. <article-title>CAMs and axonal growth: a critical evaluation of the role of calcium and the MAPK cascade</article-title>. <source>Mol Cell Neurosci</source> <volume>16</volume>(<issue>4</issue>):<fpage>283</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr42-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dusart</surname><given-names>I</given-names></name>
<name><surname>Morel</surname><given-names>MP</given-names></name>
<name><surname>Wehrlé</surname><given-names>R</given-names></name>
<name><surname>Sotelo</surname><given-names>C</given-names></name>
</person-group>. <year>1999</year>. <article-title>Late axonal sprouting of injured Purkinje cells and its temporal correlation with permissive changes in the glial scar</article-title>. <source>J Comp Neurol</source> <volume>408</volume>(<issue>3</issue>):<fpage>399</fpage>–<lpage>418</lpage>.</citation>
</ref>
<ref id="bibr43-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duveau</surname><given-names>V</given-names></name>
<name><surname>Arthaud</surname><given-names>S</given-names></name>
<name><surname>Rougier</surname><given-names>A</given-names></name>
<name><surname>Le Gal La Salle</surname><given-names>G</given-names></name>
</person-group>. <year>2007</year>. <article-title>Polysialylation of NCAM is upregulated by hyperthermia and participates in heat shock preconditioning-induced neuroprotection</article-title>. <source>Neurobiol Dis</source> <volume>26</volume>(<issue>2</issue>):<fpage>385</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr44-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Duveau</surname><given-names>V</given-names></name>
<name><surname>Fritschy</surname><given-names>JM</given-names></name>
</person-group>. <year>2010</year>. <article-title>PSA-NCAM-dependent GDNF signaling limits neurodegeneration and epileptogenesis in temporal lobe epilepsy</article-title>. <source>Eur J Neurosci</source> <volume>32</volume>(<issue>1</issue>):<fpage>89</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr45-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>El Maarouf</surname><given-names>A</given-names></name>
<name><surname>Petridis</surname><given-names>AK</given-names></name>
<name><surname>Rutishauser</surname><given-names>U</given-names></name>
</person-group>. <year>2006</year>. <article-title>Use of polysialic acid in repair of the central nervous system</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>103</volume>(<issue>45</issue>):<fpage>16989</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr46-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Emery</surname><given-names>DL</given-names></name>
<name><surname>Raghupathi</surname><given-names>R</given-names></name>
<name><surname>Saatman</surname><given-names>KE</given-names></name>
<name><surname>Fischer</surname><given-names>I</given-names></name>
<name><surname>Grady</surname><given-names>MS</given-names></name>
<name><surname>McIntosh</surname><given-names>TK</given-names></name>
</person-group>. <year>2000</year>. <article-title>Bilateral growth-related protein expression suggests a transient increase in regenerative potential following brain trauma</article-title>. <source>J Comp Neurol</source> <volume>424</volume>(<issue>3</issue>):<fpage>521</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr47-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fawcett</surname><given-names>J</given-names></name>
</person-group>. <year>2009</year>. <article-title>Molecular control of brain plasticity and repair</article-title>. <source>Prog Brain Res</source> <volume>175</volume>:<fpage>501</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr48-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fey</surname><given-names>A</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Irintchev</surname><given-names>A</given-names></name>
</person-group>. <year>2010</year>. <article-title>A novel motion analysis approach reveals late recovery in C57BL/6 mice and deficits in NCAM-deficient mice after sciatic nerve crush</article-title>. <source>J Neurotrauma</source> <volume>27</volume>(<issue>5</issue>):<fpage>815</fpage>–<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr49-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Filbin</surname><given-names>MT</given-names></name>
</person-group>. <year>2003</year>. <article-title>Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS</article-title>. <source>Nat Rev Neurosci</source> <volume>4</volume>(<issue>9</issue>):<fpage>703</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr50-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fitch</surname><given-names>MT</given-names></name>
<name><surname>Silver</surname><given-names>J</given-names></name>
</person-group>. <year>2008</year>. <article-title>CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure</article-title>. <source>Exp Neurol</source> <volume>209</volume>(<issue>2</issue>):<fpage>294</fpage>–<lpage>301</lpage>.</citation>
</ref>
<ref id="bibr51-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fox</surname><given-names>GB</given-names></name>
<name><surname>Kjøller</surname><given-names>C</given-names></name>
<name><surname>Murphy</surname><given-names>KJ</given-names></name>
<name><surname>Regan</surname><given-names>CM</given-names></name>
</person-group>. <year>2001</year>. <article-title>The modulations of NCAM polysialylation state that follow transient global ischemia are brief on neurons but enduring on glia</article-title>. <source>J Neuropathol Exp Neurol</source> <volume>60</volume>(<issue>2</issue>):<fpage>132</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr52-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Franz</surname><given-names>C</given-names></name>
<name><surname>Rutishauser</surname><given-names>U</given-names></name>
<name><surname>Rafuse</surname><given-names>V</given-names></name>
</person-group>. <year>2008</year>. <article-title>Intrinsic neuronal properties control selective targeting of regenerating motoneurons</article-title>. <source>Brain</source> <volume>131</volume>(<issue>Pt 6</issue>):<fpage>1492</fpage>–<lpage>505</lpage>.</citation>
</ref>
<ref id="bibr53-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Franz</surname><given-names>CK</given-names></name>
<name><surname>Rutishauser</surname><given-names>U</given-names></name>
<name><surname>Rafuse</surname><given-names>VF</given-names></name>
</person-group>. <year>2005</year>. <article-title>Polysialylated neural cell adhesion molecule is necessary for selective targeting of regenerating motor neurons</article-title>. <source>J Neurosci</source> <volume>25</volume>(<issue>8</issue>):<fpage>2081</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr54-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Giger</surname><given-names>RJ</given-names></name>
<name><surname>Hollis</surname><given-names>ER</given-names></name>
<name><surname>Tuszynski</surname><given-names>MH</given-names></name>
</person-group>. <year>2010</year>. <article-title>Guidance molecules in axon regeneration</article-title>. <source>Cold Spring Harb Perspect Biol</source> <volume>2</volume>(<issue>7</issue>):<fpage>a001867</fpage>.</citation>
</ref>
<ref id="bibr55-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guseva</surname><given-names>D</given-names></name>
<name><surname>Angelov</surname><given-names>D</given-names></name>
<name><surname>Irintchev</surname><given-names>A</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>2009</year>. <article-title>Ablation of adhesion molecule L1 in mice favours Schwann cell proliferation and functional recovery after peripheral nerve injury</article-title>. <source>Brain</source> <volume>132</volume>(<issue>Pt 8</issue>):<fpage>2180</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr56-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guseva</surname> <given-names>D</given-names></name>
<name><surname>Zerwas</surname><given-names>M</given-names></name>
<name><surname>Xiao</surname><given-names>MF</given-names></name>
<name><surname>Jakovcevski</surname> <given-names>I</given-names></name>
<name><surname>Irintchev</surname><given-names>A</given-names></name>
<name><surname>Schachner</surname> <given-names>M</given-names></name>
</person-group>. <year>2011</year>. <article-title>Adhesion molecule L1 overexpressed under the control of the neuronal Thy-1 promoter improves myelination after peripheral nerve injury in adult mice</article-title>. <source>Exp Neurol</source> <volume>229</volume>(<issue>2</issue>):<fpage>339</fpage>-<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr57-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gwak</surname><given-names>YS</given-names></name>
<name><surname>Hulsebosch</surname><given-names>CE</given-names></name>
</person-group>. <year>2011</year>. <article-title>GABA and central neuropathic pain following spinal cord injury</article-title>. <source>Neuropharmacology</source> <volume>60</volume>(<issue>5</issue>):<fpage>799</fpage>-<lpage>808</lpage>.</citation>
</ref>
<ref id="bibr58-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hildebrand</surname><given-names>C</given-names></name>
<name><surname>Kocsis</surname><given-names>JD</given-names></name>
<name><surname>Berglund</surname><given-names>S</given-names></name>
<name><surname>Waxman</surname><given-names>SG</given-names></name>
</person-group>. <year>1985</year>. <article-title>Myelin sheath remodelling in regenerated rat sciatic nerve</article-title>. <source>Brain Res</source> <volume>358</volume>(<issue>1–2</issue>):<fpage>163</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr59-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hillenbrand</surname><given-names>R</given-names></name>
<name><surname>Molthagen</surname><given-names>M</given-names></name>
<name><surname>Montag</surname><given-names>D</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>1999</year>. <article-title>The close homologue of the neural adhesion molecule L1 (CHL1): patterns of expression and promotion of neurite outgrowth by heterophilic interactions</article-title>. <source>Eur J Neurosci</source> <volume>11</volume>(<issue>3</issue>):<fpage>813</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr60-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holm</surname><given-names>J</given-names></name>
<name><surname>Hillenbrand</surname><given-names>R</given-names></name>
<name><surname>Steuber</surname><given-names>V</given-names></name>
<name><surname>Bartsch</surname><given-names>U</given-names></name>
<name><surname>Moos</surname><given-names>M</given-names></name>
<name><surname>Lübbert</surname><given-names>H</given-names></name>
</person-group>, and others. <year>1996</year>. <article-title>Structural features of a close homologue of L1 (CHL1) in the mouse: a new member of the L1 family of neural recognition molecules</article-title>. <source>Eur J Neurosci</source> <volume>8</volume>(<issue>8</issue>):<fpage>1613</fpage>–<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr61-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Horinouchi</surname><given-names>K</given-names></name>
<name><surname>Nakamura</surname><given-names>Y</given-names></name>
<name><surname>Yamanaka</surname><given-names>H</given-names></name>
<name><surname>Watabe</surname><given-names>T</given-names></name>
<name><surname>Shiosaka</surname><given-names>S</given-names></name>
</person-group>. <year>2005</year>. <article-title>Distribution of L1cam mRNA in the adult mouse brain: in situ hybridization and Northern blot analyses</article-title>. <source>J Comp Neurol</source> <volume>482</volume>(<issue>4</issue>):<fpage>386</fpage>–<lpage>404</lpage>.</citation>
</ref>
<ref id="bibr62-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hortsch</surname><given-names>M</given-names></name>
</person-group>. <year>2003</year>. <article-title>Neural cell adhesion molecules—brain glue and much more!</article-title> <source>Front Biosci</source> <volume>8</volume>:<fpage>d357</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr63-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hoschouer</surname><given-names>EL</given-names></name>
<name><surname>Yin</surname><given-names>FQ</given-names></name>
<name><surname>Jakeman</surname><given-names>LB</given-names></name>
</person-group>. <year>2009</year>. <article-title>L1 cell adhesion molecule is essential for the maintenance of hyperalgesia after spinal cord injury</article-title>. <source>Exp Neurol</source> <volume>216</volume>(<issue>1</issue>):<fpage>22</fpage>–<lpage>34</lpage>.</citation>
</ref>
<ref id="bibr64-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Irving</surname><given-names>EA</given-names></name>
<name><surname>Vinson</surname><given-names>M</given-names></name>
<name><surname>Rosin</surname><given-names>C</given-names></name>
<name><surname>Roberts</surname><given-names>JC</given-names></name>
<name><surname>Chapman</surname><given-names>DM</given-names></name>
<name><surname>Facci</surname><given-names>L</given-names></name>
</person-group>, and others. <year>2005</year>. <article-title>Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke?</article-title> <source>J Cereb Blood Flow Metab</source> <volume>25</volume>(<issue>1</issue>):<fpage>98</fpage>–<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr65-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jakovcevski</surname><given-names>I</given-names></name>
<name><surname>Mo</surname><given-names>Z</given-names></name>
<name><surname>Zecevic</surname><given-names>N</given-names></name>
</person-group>. <year>2007</year>. <article-title>Down-regulation of the axonal polysialic acid-neural cell adhesion molecule expression coincides with the onset of myelination in the human fetal forebrain</article-title>. <source>Neuroscience</source> <volume>149</volume>(<issue>2</issue>):<fpage>328</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr66-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jakovcevski</surname><given-names>I</given-names></name>
<name><surname>Wu</surname><given-names>J</given-names></name>
<name><surname>Karl</surname><given-names>N</given-names></name>
<name><surname>Leshchyns’ka</surname><given-names>I</given-names></name>
<name><surname>Sytnyk</surname><given-names>V</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
</person-group>, and others. <year>2007</year>. <article-title>Glial scar expression of CHL1, the close homolog of the adhesion molecule L1, limits recovery after spinal cord injury</article-title>. <source>J Neurosci</source> <volume>27</volume>(<issue>27</issue>):<fpage>7222</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr67-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jucker</surname><given-names>M</given-names></name>
<name><surname>D’Amato</surname><given-names>F</given-names></name>
<name><surname>Mondadori</surname><given-names>C</given-names></name>
<name><surname>Mohajeri</surname><given-names>H</given-names></name>
<name><surname>Magyar</surname><given-names>J</given-names></name>
<name><surname>Bartsch</surname><given-names>U</given-names></name>
</person-group>, and others. <year>1996</year>. <article-title>Expression of the neural adhesion molecule L1 in the deafferented dentate gyrus</article-title>. <source>Neuroscience</source> <volume>75</volume>(<issue>3</issue>):<fpage>703</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr68-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jucker</surname><given-names>M</given-names></name>
<name><surname>Mondadori</surname><given-names>C</given-names></name>
<name><surname>Mohajeri</surname><given-names>H</given-names></name>
<name><surname>Bartsch</surname><given-names>U</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>1995</year>. <article-title>Transient upregulation of NCAM mRNA in astrocytes in response to entorhinal cortex lesions and ischemia</article-title>. <source>Brain Res Mol Brain Res</source> <volume>28</volume>(<issue>1</issue>):<fpage>149</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr69-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jung</surname><given-names>M</given-names></name>
<name><surname>Petrausch</surname><given-names>B</given-names></name>
<name><surname>Stuermer</surname><given-names>CA</given-names></name>
</person-group>. <year>1997</year>. <article-title>Axon-regenerating retinal ganglion cells in adult rats synthesize the cell adhesion molecule L1 but not TAG-1 or SC-1</article-title>. <source>Mol Cell Neurosci</source> <volume>9</volume>(<issue>2</issue>):<fpage>116</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr70-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Karimi-Abdolrezaee</surname><given-names>S</given-names></name>
<name><surname>Eftekharpour</surname><given-names>E</given-names></name>
<name><surname>Wang</surname><given-names>J</given-names></name>
<name><surname>Schut</surname><given-names>D</given-names></name>
<name><surname>Fehlings</surname><given-names>MG</given-names></name>
</person-group>. <year>2010</year>. <article-title>Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord</article-title>. <source>J Neurosci</source> <volume>30</volume>(<issue>5</issue>):<fpage>1657</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr71-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>BG</given-names></name>
<name><surname>Dai</surname><given-names>HN</given-names></name>
<name><surname>McAtee</surname><given-names>M</given-names></name>
<name><surname>Vicini</surname><given-names>S</given-names></name>
<name><surname>Bregman</surname><given-names>BS</given-names></name>
</person-group>. <year>2006</year>. <article-title>Remodeling of synaptic structures in the motor cortex following spinal cord injury</article-title>. <source>Exp Neurol</source> <volume>198</volume>(<issue>2</issue>):<fpage>401</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr72-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>JE</given-names></name>
<name><surname>Liu</surname><given-names>BP</given-names></name>
<name><surname>Park</surname><given-names>JH</given-names></name>
<name><surname>Strittmatter</surname><given-names>SM</given-names></name>
</person-group>. <year>2004</year>. <article-title>Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury</article-title>. <source>Neuron</source> <volume>44</volume>(<issue>3</issue>):<fpage>439</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr73-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kleene</surname><given-names>R</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>2004</year>. <article-title>Glycans and neural cell interactions</article-title>. <source>Nat Rev Neurosci</source> <volume>5</volume>(<issue>3</issue>):<fpage>195</fpage>–<lpage>208</lpage>.</citation>
</ref>
<ref id="bibr74-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Klementiev</surname><given-names>B</given-names></name>
<name><surname>Novikova</surname><given-names>T</given-names></name>
<name><surname>Korshunova</surname><given-names>I</given-names></name>
<name><surname>Berezin</surname><given-names>V</given-names></name>
<name><surname>Bock</surname><given-names>E</given-names></name>
</person-group>. <year>2008</year>. <article-title>The NCAM-derived P2 peptide facilitates recovery of cognitive and motor function and ameliorates neuropathology following traumatic brain injury</article-title>. <source>Eur J Neurosci</source> <volume>27</volume>(<issue>11</issue>):<fpage>2885</fpage>–<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr75-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kruse</surname><given-names>J</given-names></name>
<name><surname>Mailhammer</surname><given-names>R</given-names></name>
<name><surname>Wernecke</surname><given-names>H</given-names></name>
<name><surname>Faissner</surname><given-names>A</given-names></name>
<name><surname>Sommer</surname><given-names>I</given-names></name>
<name><surname>Goridis</surname><given-names>C</given-names></name>
</person-group>, and others. <year>1984</year>. <article-title>Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1</article-title>. <source>Nature</source> <volume>311</volume>(<issue>5982</issue>):<fpage>153</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr76-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Langenfeld-Oster</surname><given-names>B</given-names></name>
<name><surname>Faissner</surname><given-names>A</given-names></name>
<name><surname>Irintchev</surname><given-names>A</given-names></name>
<name><surname>Wernig</surname><given-names>A</given-names></name>
</person-group>. <year>1994</year>. <article-title>Polyclonal antibodies against NCAM and tenascin delay endplate reinnervation</article-title>. <source>J Neurocytol</source> <volume>23</volume>(<issue>19</issue>):<fpage>591</fpage>–<lpage>604</lpage>.</citation>
</ref>
<ref id="bibr77-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lavdas</surname><given-names>AA</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
<name><surname>Papastefanaki</surname><given-names>F</given-names></name>
<name><surname>Chen</surname><given-names>S</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Matsas</surname><given-names>R</given-names></name>
</person-group>, and others. <year>2010</year>. <article-title>Schwann cells engineered to express the cell adhesion molecule L1 accelerate myelination and motor recovery after spinal cord injury</article-title>. <source>Exp Neurol</source> <volume>221</volume>(<issue>1</issue>):<fpage>206</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr78-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>JK</given-names></name>
<name><surname>Geoffroy</surname><given-names>CG</given-names></name>
<name><surname>Chan</surname><given-names>AF</given-names></name>
<name><surname>Tolentino</surname><given-names>KE</given-names></name>
<name><surname>Crawford</surname><given-names>MJ</given-names></name>
<name><surname>Leal</surname><given-names>MA</given-names></name>
</person-group>, and others. <year>2010</year>. <article-title>Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice</article-title>. <source>Neuron</source> <volume>66</volume>(<issue>5</issue>):<fpage>663</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr79-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Loers</surname><given-names>G</given-names></name>
<name><surname>Chen</surname><given-names>S</given-names></name>
<name><surname>Grumet</surname><given-names>M</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>2005</year>. <article-title>Signal transduction pathways implicated in neural recognition molecule L1 triggered neuroprotection and neuritogenesis</article-title>. <source>J Neurochem</source> <volume>92</volume>(<issue>6</issue>):<fpage>1463</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr80-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Loers</surname><given-names>G</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>2007</year>. <article-title>Recognition molecules and neural repair</article-title>. <source>J Neurochem</source> <volume>101</volume>(<issue>4</issue>):<fpage>865</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr81-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lundborg</surname><given-names>G</given-names></name>
<name><surname>Rosén</surname><given-names>B</given-names></name>
</person-group>. <year>2007</year>. <article-title>Hand function after nerve repair</article-title>. <source>Acta Physiol (Oxf)</source> <volume>189</volume>(<issue>2</issue>):<fpage>207</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr82-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maness</surname><given-names>PF</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>2007</year>. <article-title>Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration</article-title>. <source>Nat Neurosci</source> <volume>10</volume>(<issue>1</issue>):<fpage>19</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr83-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marino</surname><given-names>P</given-names></name>
<name><surname>Norreel</surname><given-names>JC</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Rougon</surname><given-names>G</given-names></name>
<name><surname>Amoureux</surname><given-names>MC</given-names></name>
</person-group>. <year>2009</year>. <article-title>A polysialic acid mimetic peptide promotes functional recovery in a mouse model of spinal cord injury</article-title>. <source>Exp Neurol</source> <volume>219</volume>(<issue>1</issue>):<fpage>163</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr84-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martini</surname><given-names>R</given-names></name>
</person-group>. <year>1994</year>. <article-title>Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves</article-title>. <source>J Neurocytol</source> <volume>23</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr85-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martini</surname><given-names>R</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
</person-group>. <year>1988</year>. <article-title>Immunoelectron microscopic localization of neural cell adhesion molecules (L1, N-CAM, and myelin-associated glycoprotein) in regenerating adult mouse sciatic nerve</article-title>. <source>J Cell Biol</source> <volume>106</volume>(<issue>5</issue>):<fpage>1735</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr86-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martini</surname><given-names>R</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Brushart</surname><given-names>TM</given-names></name>
</person-group>. <year>1994</year>. <article-title>The L2/HNK-1 carbohydrate is preferentially expressed by previously motor axon-associated Schwann cells in reinnervated peripheral nerves</article-title>. <source>J Neurosci</source> <volume>14</volume>(<issue>11, Pt 2</issue>):<fpage>7180</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr87-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mason</surname><given-names>MR</given-names></name>
<name><surname>Lieberman</surname><given-names>AR</given-names></name>
<name><surname>Anderson</surname><given-names>PN</given-names></name>
</person-group>. <year>2003</year>. <article-title>Corticospinal neurons up-regulate a range of growth-associated genes following intracortical, but not spinal, axotomy</article-title>. <source>Eur J Neurosci</source> <volume>18</volume>(<issue>4</issue>):<fpage>789</fpage>–<lpage>802</lpage>.</citation>
</ref>
<ref id="bibr88-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mears</surname><given-names>S</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Brushart</surname><given-names>TM</given-names></name>
</person-group>. <year>2003</year>. <article-title>Antibodies to myelin-associated glycoprotein accelerate preferential motor reinnervation</article-title>. <source>J Peripher Nerv Syst</source> <volume>8</volume>(<issue>2</issue>):<fpage>91</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr89-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mehanna</surname><given-names>A</given-names></name>
<name><surname>Jakovcevski</surname><given-names>I</given-names></name>
<name><surname>Acar</surname><given-names>A</given-names></name>
<name><surname>Xiao</surname><given-names>M</given-names></name>
<name><surname>Loers</surname><given-names>G</given-names></name>
<name><surname>Rougon</surname><given-names>G</given-names></name>
</person-group>, and others. <year>2010</year>. <article-title>Polysialic acid glycomimetic promotes functional recovery and plasticity after spinal cord injury in mice</article-title>. <source>Mol Ther</source> <volume>18</volume>(<issue>1</issue>):<fpage>34</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr90-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mehanna</surname><given-names>A</given-names></name>
<name><surname>Mishra</surname><given-names>B</given-names></name>
<name><surname>Kurschat</surname><given-names>N</given-names></name>
<name><surname>Schulze</surname><given-names>C</given-names></name>
<name><surname>Bian</surname><given-names>S</given-names></name>
<name><surname>Loers</surname><given-names>G</given-names></name>
</person-group>, and others. <year>2009</year>. <article-title>Polysialic acid glycomimetics promote myelination and functional recovery after peripheral nerve injury in mice</article-title>. <source>Brain</source> <volume>132</volume>(<issue>Pt 6</issue>):<fpage>1449</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr91-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meijs</surname><given-names>MF</given-names></name>
<name><surname>Timmers</surname><given-names>L</given-names></name>
<name><surname>Pearse</surname><given-names>DD</given-names></name>
<name><surname>Tresco</surname><given-names>PA</given-names></name>
<name><surname>Bates</surname><given-names>ML</given-names></name>
<name><surname>Joosten</surname><given-names>EA</given-names></name>
</person-group>, and others. <year>2004</year>. <article-title>Basic fibroblast growth factor promotes neuronal survival but not behavioral recovery in the transected and Schwann cell implanted rat thoracic spinal cord</article-title>. <source>J Neurotrauma</source> <volume>21</volume>(<issue>10</issue>):<fpage>1415</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr92-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mishra</surname><given-names>B</given-names></name>
<name><surname>von der Ohe</surname><given-names>M</given-names></name>
<name><surname>Schulze</surname><given-names>C</given-names></name>
<name><surname>Bian</surname><given-names>S</given-names></name>
<name><surname>Makhina</surname><given-names>T</given-names></name>
<name><surname>Loers</surname><given-names>G</given-names></name>
</person-group>, and others. <year>2010</year>. <article-title>Functional role of the interaction between polysialic acid and extracellular histone H1</article-title>. <source>J Neurosci</source> <volume>30</volume>(<issue>37</issue>):<fpage>12400</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr93-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>JA</given-names></name>
<name><surname>Hartwick</surname><given-names>AT</given-names></name>
<name><surname>Rutishauser</surname><given-names>U</given-names></name>
<name><surname>Clarke</surname><given-names>DB</given-names></name>
</person-group>. <year>2009</year>. <article-title>Endogenous polysialylated neural cell adhesion molecule enhances the survival of retinal ganglion cells</article-title>. <source>Invest Ophthalmol Vis Sci</source> <volume>50</volume>(<issue>2</issue>):<fpage>861</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr94-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nakamura</surname><given-names>Y</given-names></name>
<name><surname>Fujita</surname><given-names>Y</given-names></name>
<name><surname>Ueno</surname><given-names>M</given-names></name>
<name><surname>Takai</surname><given-names>T</given-names></name>
<name><surname>Yamashita</surname><given-names>T</given-names></name>
</person-group>. <year>2011</year>. <article-title>Paired immunoglobulin-like receptor B knockout does not enhance axonal regeneration or locomotor recovery after spinal cord injury</article-title>. <source>J Biol Chem</source> <volume>286</volume>(<issue>3</issue>):<fpage>1876</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr95-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nikonenko</surname><given-names>A</given-names></name>
<name><surname>Sun</surname><given-names>M</given-names></name>
<name><surname>Lepsveridze</surname><given-names>E</given-names></name>
<name><surname>Apostolova</surname><given-names>I</given-names></name>
<name><surname>Petrova</surname><given-names>I</given-names></name>
<name><surname>Irintchev</surname><given-names>A</given-names></name>
</person-group>, and others. <year>2006</year>. <article-title>Enhanced perisomatic inhibition and impaired long-term potentiation in the CA1 region of juvenile CHL1-deficient mice</article-title>. <source>Eur J Neurosci</source> <volume>23</volume>(<issue>7</issue>):<fpage>1839</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr96-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Omoto</surname><given-names>S</given-names></name>
<name><surname>Ueno</surname><given-names>M</given-names></name>
<name><surname>Mochio</surname><given-names>S</given-names></name>
<name><surname>Takai</surname><given-names>T</given-names></name>
<name><surname>Yamashita</surname><given-names>T</given-names></name>
</person-group>. <year>2010</year>. <article-title>Genetic deletion of paired immunoglobulin-like receptor B does not promote axonal plasticity or functional recovery after traumatic brain injury</article-title>. <source>J Neurosci</source> <volume>30</volume>(<issue>39</issue>):<fpage>13045</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr97-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ourednik</surname><given-names>V</given-names></name>
<name><surname>Ourednik</surname><given-names>J</given-names></name>
<name><surname>Xu</surname><given-names>Y</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Lynch</surname><given-names>WP</given-names></name>
<name><surname>Snyder</surname><given-names>EY</given-names></name>
</person-group>, and others. <year>2009</year>. <article-title>Cross-talk between stem cells and the dysfunctional brain is facilitated by manipulating the niche: evidence from an adhesion molecule</article-title>. <source>Stem Cells</source> <volume>27</volume>(<issue>11</issue>):<fpage>2846</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr98-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Papastefanaki</surname><given-names>F</given-names></name>
<name><surname>Chen</surname><given-names>J</given-names></name>
<name><surname>Lavdas</surname><given-names>AA</given-names></name>
<name><surname>Thomaidou</surname><given-names>D</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Matsas</surname><given-names>R</given-names></name>
</person-group>. <year>2007</year>. <article-title>Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury</article-title>. <source>Brain</source> <volume>130</volume>(<issue>Pt 8</issue>):<fpage>2159</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr99-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Quarles</surname><given-names>RH</given-names></name>
</person-group>. <year>2007</year>. <article-title>Myelin-associated glycoprotein (MAG): past, present and beyond</article-title>. <source>J Neurochem</source> <volume>100</volume>(<issue>6</issue>):<fpage>1431</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr100-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Roonprapunt</surname><given-names>C</given-names></name>
<name><surname>Huang</surname><given-names>W</given-names></name>
<name><surname>Grill</surname><given-names>R</given-names></name>
<name><surname>Friedlander</surname><given-names>D</given-names></name>
<name><surname>Grumet</surname><given-names>M</given-names></name>
<name><surname>Chen</surname><given-names>S</given-names></name>
</person-group>, and others. <year>2003</year>. <article-title>Soluble cell adhesion molecule L1-Fc promotes locomotor recovery in rats after spinal cord injury</article-title>. <source>J Neurotrauma</source> <volume>20</volume>(<issue>9</issue>):<fpage>871</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr101-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rougon</surname><given-names>G</given-names></name>
<name><surname>Hobert</surname><given-names>O</given-names></name>
</person-group>. <year>2003</year>. <article-title>New insights into the diversity and function of neuronal immunoglobulin superfamily molecules</article-title>. <source>Annu Rev Neurosci</source> <volume>26</volume>:<fpage>207</fpage>–<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr102-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Runyan</surname><given-names>SA</given-names></name>
<name><surname>Roy</surname><given-names>RR</given-names></name>
<name><surname>Zhong</surname><given-names>H</given-names></name>
<name><surname>Phelps</surname><given-names>PE</given-names></name>
</person-group>. <year>2007</year>. <article-title>L1 cell adhesion molecule is not required for small-diameter primary afferent sprouting after deafferentation</article-title>. <source>Neuroscience</source> <volume>150</volume>(<issue>4</issue>):<fpage>959</fpage>–<lpage>69</lpage>.</citation>
</ref>
<ref id="bibr103-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sakai</surname><given-names>A</given-names></name>
<name><surname>Asada</surname><given-names>M</given-names></name>
<name><surname>Seno</surname><given-names>N</given-names></name>
<name><surname>Suzuki</surname><given-names>H</given-names></name>
</person-group>. <year>2008</year>. <article-title>Involvement of neural cell adhesion molecule signaling in glial cell line–derived neurotrophic factor-induced analgesia in a rat model of neuropathic pain</article-title>. <source>Pain</source> <volume>137</volume>(<issue>2</issue>):<fpage>378</fpage>–<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr104-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schäfer</surname><given-names>M</given-names></name>
<name><surname>Fruttiger</surname><given-names>M</given-names></name>
<name><surname>Montag</surname><given-names>D</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Martini</surname><given-names>R</given-names></name>
</person-group>. <year>1996</year>. <article-title>Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wlds mice</article-title>. <source>Neuron</source> <volume>16</volume>(<issue>6</issue>):<fpage>1107</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr105-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schmid</surname><given-names>RS</given-names></name>
<name><surname>Maness</surname><given-names>PF</given-names></name>
</person-group>. <year>2008</year>. <article-title>L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth</article-title>. <source>Curr Opin Neurobiol</source> <volume>18</volume>(<issue>3</issue>):<fpage>245</fpage>–<lpage>50</lpage>.</citation>
</ref>
<ref id="bibr106-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Scholz</surname><given-names>T</given-names></name>
<name><surname>Krichevsky</surname><given-names>A</given-names></name>
<name><surname>Sumarto</surname><given-names>A</given-names></name>
<name><surname>Jaffurs</surname><given-names>D</given-names></name>
<name><surname>Wirth</surname><given-names>GA</given-names></name>
<name><surname>Paydar</surname><given-names>K</given-names></name>
</person-group>, and others. <year>2009</year>. <article-title>Peripheral nerve injuries: an international survey of current treatments and future perspectives</article-title>. <source>J Reconstr Microsurg</source> <volume>25</volume>(<issue>6</issue>):<fpage>339</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr107-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shapiro</surname><given-names>L</given-names></name>
<name><surname>Love</surname><given-names>J</given-names></name>
<name><surname>Colman</surname><given-names>DR</given-names></name>
</person-group>. <year>2007</year>. <article-title>Adhesion molecules in the nervous system: structural insights into function and diversity</article-title>. <source>Annu Rev Neurosci</source> <volume>30</volume>:<fpage>451</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr108-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simova</surname><given-names>O</given-names></name>
<name><surname>Irintchev</surname><given-names>A</given-names></name>
<name><surname>Mehanna</surname><given-names>A</given-names></name>
<name><surname>Liu</surname><given-names>J</given-names></name>
<name><surname>Dihne</surname><given-names>M</given-names></name>
<name><surname>Bachle</surname><given-names>D</given-names></name>
</person-group>, and others. <year>2006</year>. <article-title>Carbohydrate mimics promote functional recovery after peripheral nerve repair</article-title>. <source>Ann Neurol</source> <volume>60</volume>(<issue>4</issue>):<fpage>430</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr109-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sofroniew</surname><given-names>MV</given-names></name>
<name><surname>Vinters</surname><given-names>HV</given-names></name>
</person-group>. <year>2010</year>. <article-title>Astrocytes: biology and pathology</article-title>. <source>Acta Neuropathol</source> <volume>119</volume>(<issue>1</issue>):<fpage>7</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr110-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Styren</surname><given-names>SD</given-names></name>
<name><surname>Miller</surname><given-names>PD</given-names></name>
<name><surname>Lagenaur</surname><given-names>CF</given-names></name>
<name><surname>DeKosky</surname><given-names>ST</given-names></name>
</person-group>. <year>1995</year>. <article-title>Alternate strategies in lesion-induced reactive synaptogenesis: differential expression of L1 in two populations of sprouting axons</article-title>. <source>Exp Neurol</source> <volume>131</volume>(<issue>2</issue>):<fpage>165</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr111-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Teng</surname><given-names>YD</given-names></name>
<name><surname>Mocchetti</surname><given-names>I</given-names></name>
<name><surname>Taveira-DaSilva</surname><given-names>AM</given-names></name>
<name><surname>Gillis</surname><given-names>RA</given-names></name>
<name><surname>Wrathall</surname><given-names>JR</given-names></name>
</person-group>. <year>1999</year>. <article-title>Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury</article-title>. <source>J Neurosci</source> <volume>19</volume>(<issue>16</issue>):<fpage>7037</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr112-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tomita</surname><given-names>K</given-names></name>
<name><surname>Kubo</surname><given-names>T</given-names></name>
<name><surname>Matsuda</surname><given-names>K</given-names></name>
<name><surname>Yano</surname><given-names>K</given-names></name>
<name><surname>Tohyama</surname><given-names>M</given-names></name>
<name><surname>Hosokawa</surname><given-names>K</given-names></name>
</person-group>. <year>2007</year>. <article-title>Myelin-associated glycoprotein reduces axonal branching and enhances functional recovery after sciatic nerve transection in rats</article-title>. <source>Glia</source> <volume>55</volume>(<issue>14</issue>):<fpage>1498</fpage>–<lpage>507</lpage>.</citation>
</ref>
<ref id="bibr113-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Troncoso</surname><given-names>E</given-names></name>
<name><surname>Muller</surname><given-names>D</given-names></name>
<name><surname>Korodi</surname><given-names>K</given-names></name>
<name><surname>Steimer</surname><given-names>T</given-names></name>
<name><surname>Welker</surname><given-names>E</given-names></name>
<name><surname>Kiss</surname><given-names>JZ</given-names></name>
</person-group>. <year>2004</year>. <article-title>Recovery of evoked potentials, metabolic activity and behavior in a mouse model of somatosensory cortex lesion: role of the neural cell adhesion molecule (NCAM)</article-title>. <source>Cereb Cortex</source> <volume>14</volume>(<issue>3</issue>):<fpage>332</fpage>–<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr114-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Walsh</surname><given-names>FS</given-names></name>
<name><surname>Doherty</surname><given-names>P</given-names></name>
</person-group>. <year>1997</year>. <article-title>Neural cell adhesion molecules of the immunoglobulin superfamily: role in axon growth and guidance</article-title>. <source>Annu Rev Cell Dev Biol</source> <volume>13</volume>:<fpage>425</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr115-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Woolf</surname><given-names>CJ</given-names></name>
<name><surname>Mannion</surname><given-names>RJ</given-names></name>
</person-group>. <year>1999</year>. <article-title>Neuropathic pain: aetiology, symptoms, mechanisms, and management</article-title>. <source>Lancet</source> <volume>353</volume>(<issue>9168</issue>): <fpage>1959</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr116-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Woolhead</surname><given-names>CL</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Lieberman</surname><given-names>AR</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Emson</surname><given-names>PC</given-names></name>
<name><surname>Anderson</surname><given-names>PN</given-names></name>
</person-group>. <year>1998</year>. <article-title>Differential effects of autologous peripheral nerve grafts to the corpus striatum of adult rats on the regeneration of axons of striatal and nigral neurons and on the expression of GAP-43 and the cell adhesion molecules N-CAM and L1</article-title>. <source>J Comp Neurol</source> <volume>391</volume>(<issue>2</issue>):<fpage>259</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr117-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>B</given-names></name>
<name><surname>Ren</surname><given-names>X</given-names></name>
</person-group>. <year>2009</year>. <article-title>Promoting axonal myelination for improving neurological recovery in spinal cord injury</article-title>. <source>J Neurotrauma</source> <volume>26</volume>(<issue>10</issue>):<fpage>1847</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr118-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yamanaka</surname><given-names>H</given-names></name>
<name><surname>Obata</surname><given-names>K</given-names></name>
<name><surname>Kobayashi</surname><given-names>K</given-names></name>
<name><surname>Dai</surname><given-names>Y</given-names></name>
<name><surname>Fukuoka</surname><given-names>T</given-names></name>
<name><surname>Noguchi</surname><given-names>K</given-names></name>
</person-group>. <year>2007</year>. <article-title>Alteration of the cell adhesion molecule L1 expression in a specific subset of primary afferent neurons contributes to neuropathic pain</article-title>. <source>Eur J Neurosci</source> <volume>25</volume>(<issue>4</issue>): <fpage>1097</fpage>–<lpage>111</lpage>.</citation>
</ref>
<ref id="bibr119-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>S</given-names></name>
<name><surname>Xia</surname><given-names>YY</given-names></name>
<name><surname>Lim</surname><given-names>HC</given-names></name>
<name><surname>Tang</surname><given-names>FR</given-names></name>
<name><surname>Feng</surname><given-names>ZW</given-names></name>
</person-group>. <year>2010</year>. <article-title>NCAM-mediated locomotor recovery from spinal cord contusion injury involves neuroprotection, axon regeneration, and synaptogenesis</article-title>. <source>Neurochem Int</source> <volume>56</volume>(<issue>8</issue>):<fpage>919</fpage>–<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr120-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Bo</surname><given-names>X</given-names></name>
<name><surname>Schoepfer</surname><given-names>R</given-names></name>
<name><surname>Holtmaat</surname><given-names>AJ</given-names></name>
<name><surname>Verhaagen</surname><given-names>J</given-names></name>
<name><surname>Emson</surname><given-names>PC</given-names></name>
</person-group>, and others. <year>2005</year>. <article-title>Growth-associated protein GAP-43 and L1 act synergistically to promote regenerative growth of Purkinje cell axons in vivo</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>102</volume>(<issue>41</issue>):<fpage>14883</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr121-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Campbell</surname><given-names>G</given-names></name>
<name><surname>Anderson</surname><given-names>PN</given-names></name>
<name><surname>Martini</surname><given-names>R</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Lieberman</surname><given-names>AR</given-names></name>
</person-group>. <year>1995</year>. <article-title>Molecular basis of interactions between regenerating adult rat thalamic axons and Schwann cells in peripheral nerve grafts: I. Neural cell adhesion molecules</article-title>. <source>J Comp Neurol</source> <volume>361</volume>(<issue>2</issue>):<fpage>193</fpage>–<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr122-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Roslan</surname><given-names>R</given-names></name>
<name><surname>Lang</surname><given-names>D</given-names></name>
<name><surname>Schachner</surname><given-names>M</given-names></name>
<name><surname>Lieberman</surname><given-names>AR</given-names></name>
<name><surname>Anderson</surname><given-names>PN</given-names></name>
</person-group>. <year>2000</year>. <article-title>Expression of CHL1 and L1 by neurons and glia following sciatic nerve and dorsal root injury</article-title>. <source>Mol Cell Neurosci</source> <volume>16</volume>(<issue>1</issue>):<fpage>71</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr123-1073858411419047">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Yeh</surname><given-names>J</given-names></name>
<name><surname>Richardson</surname><given-names>PM</given-names></name>
<name><surname>Bo</surname><given-names>X</given-names></name>
</person-group>. <year>2008</year>. <article-title>Cell adhesion molecules of the immunoglobulin superfamily in axonal regeneration and neural repair</article-title>. <source>Restor Neurol Neurosci</source> <volume>26</volume>(<issue>2–3</issue>):<fpage>81</fpage>–<lpage>96</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>